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ABSTRACT OF DISSERTATION 
 
FORMATION OF THE ETHER BRIDGE IN THE LOLINE ALKALOID 
BIOSYNTHETIC PATHWAY 
Lolines are specialized metabolites produced by endophytic fungi, such as 
Neotyphodium and Epichloë species, that are in symbiotic relationships with cool-season 
grasses. Lolines are vital for the survival of the grasses because their insecticidal and 
antifeedant properties protect the plant from insect herbivory. Although lolines have 
various bioactivities, they do not have any concomitant antimammalian activities. 
Lolines have complex structures that are unique among naturally occurring 
pyrrolizidine alkaloids. Lolines have four contiguous stereocenters, and they contain an 
ether bridge connecting C(2) and C(7) of the pyrrolizidine ring. An ether bridge connecting 
bridgehead C atoms is unusual in natural products and leads to interesting questions about 
the biosynthesis of lolines in fungal endophytes. 
Dr. Pan, who was a graduate student in Dr. Schardl Lab at University of Kentucky, 
isolated a novel metabolite, 1-exo-acetamidopyrrolizidine (AcAP). She observed that 
AcAP was accumulating in naturally occurring and artificial lolO mutants. I synthesized 
an authentic sample of (±)-AcAP and compared it spectroscopically with AcAP isolated 
from a lolO mutant to determine the structure and stereochemistry of the natural product. I 
was also able to grow crystals of synthetic (±)-AcAP, X-ray analysis of which further 
supported our structure assignment. 
There were two possible explanations for the fact that a missing or nonfunctional 
LolO led to the accumulation of AcAP: that AcAP was the actual substrate of LolO, or that 
it was a shunt product derived from the real substrate of LolO, 1-exo-aminopyrrolizidine 
(AP), and that was produced only when LolO was not available to oxidize AP. To 
distinguish between the two hypotheses, I synthesized 2´,2´,2´,3-[2H4]-AcAP. Dr. Pan used 
this material to confirm that AcAP was an intermediate in loline alkaloid biosynthesis, not 
a shunt product.  
To determine the product of LolO acting on AcAP, Dr. Pan expressed LolO in yeast 
(Saccharomyces cerevisiae). When Dr. Pan fed AcAP (synthesized by me) to the modified 
organism, it produced NANL, suggesting that LolO catalyzed two C–H activations of 
AcAP and the formation of both C–O bonds of the ether bridge in NANL, a highly unusual 
transformation. Dr. Chang then cloned, expressed, and purified LolO and incubated it with 
(±)-AcAP, 2-oxoglutarate, and O2. He observed the production of NANL, further 
confirming the function of LolO. Dr. Chang also observed an intermediate, which we 
tentatively identified as 2-hydroxy-AcAP.  
In order to determine whether the initial hydroxylation of AcAP catalyzed by LolO 
occurred at C(2) or C(7), I prepared (±)-7,7-[2H2]- and (±)-2,2,8-[
2H3]-AcAP. When Dr. 
Pan measured the rate of LolO-catalyzed hydroxylation of these substrates under 
conditions under which only one C–H activation would occur, she observed a very large 
kinetic isotope effect when C(2) was deuterated, but not when C(7) was deuterated, 
establishing that the initial hydroxylation of AcAP occurred at the C(2) position.  
 
In order to determine the stereochemical course of C–H bond oxidation by LolO at 
C(2) and C(7) of AcAP, I synthesized trans- and cis-3-[2H]-Pro and (2S,3R)-3-[2H]- and 
(2S,3S)-2,3-[2H2]-Asp. Feeding experiments with these substrates carried out by both Dr. 
Pan (Pro) and me (Asp) showed that at both the C(2) and C(7) positions of AcAP, LolO 
abstracted the endo H atoms during ether bridge formation.  
In summary, feeding experiments with deuterated (±)-AcAP derivatives and its 
amino acid precursors have shown that AcAP is an intermediate in loline biosynthesis. We 
have shown that LolO catalyzes the four-electron oxidation of AcAP at the endo C(2) 
position first and then the endo C(7) position to give NANL.  
KEYWORDS: Loline, biosynthesis, pyrrolizidine, LolO, C–H activation 
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 1 
Chapter 1. Introduction
 
 Aim and scope of this study 
 
As part of a study to establish the intermediates and elucidate the role of LolO 
enzyme in the loline alkaloid biosynthetic pathway.  
In this report, I describe the isolation of a previously unknown metabolite from 
naturally occurring and artificial lolO mutants. To determine the structure and 
stereochemistry of this compound, I synthesized an authentic sample of (±)-AcAP, 
demonstrated its stereochemistry, and showed its spectroscopic identity with the metabolite 
isolated from the endophyte. I describe the synthesis of deuterium-labeled AcAP 
isotopologues, which was then used to confirm that AcAP was an intermediate in loline 
alkaloid biosynthesis, not a shunt product (Scheme 1.1).  
 
Scheme 1.1. AcAP as an intermediate in loline biosynthesis. Showing incorporation of D 
atom in NANL from d4-AcAP. 
In this report, I also describe our investigation to determine what is the product of 
LolO acting on AcAP. The experiments involved feeding AcAP to yeast that was 
genetically modified with LolO and also to cloned, expressed, and purified LolO. Both 
experiments resulted in the production of NANL. The feeding to purified LolO revealed a 
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new intermediate between AcAP and NANL, which we tentatively identify as hydroxy-
AcAP (Scheme 1.2). 
 
 
Scheme 1.2. Presence of hydroxy intermediate produce during the oxidation of AcAP to 
NANL by LolO. 
In this report, I describe an independent confirmation of the sequence of C–H 
activation events. In order to determine whether the initial hydroxylation of AcAP 
catalyzed by LolO occurred at C(2) or C(7), I prepared (±)-7,7-[2H2]- and (±)-2,2,8-[
2H3]-
AcAP. Stop-flow kinetics experiments by Dr. Juan Pan with 2,2,8-[2H3]- and 7,7-[
2H2]-
AcAP under single-oxidation conditions revealed a very large kinetic isotope effect in the 
former case, but not in the latter, establishing that the initial hydroxylation of AcAP 
occurred at the C(2) position. Dr. Juan Pan was able to isolate 2-hydroxy AcAP from 
unreacted ACAP and the product NANL. With the help of 1H NMR, 1H-1H COSY and 
NOE experiments, I was able to establish the structure and stereochemistry of isolated 
compound as 2-endo-2-hydroxy AcAP (Scheme 1.3). 
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Scheme 1.3. Initial Hydroxylation of AcAP at C(2) position on endo face. 
In this report, I describes the investigation of the stereochemical course of C–H 
bond activation by LolO at C(2) and C(7) of AcAP. I synthesized trans- and cis-3-[2H]-
Pro and (3R)-3-[2H]- and (3S)-2,3-[2H2]-Asp. Feeding experiments with these substrates 
carried out by both Dr. Pan (Pro) and me (Asp) showed that at both the C(2) and C(7) 
positions of AcAP, LolO abstracted the endo H atoms during ether bridge formation 
(Scheme 1.4).  
 
Scheme 1.4. Abstraction of endo H atoms from C(2) and C(7) of AcAP by LolO. 
 
 Endophytes and their interaction with host plants 
Endophytes are organisms that flourish intercellularly in host plants, with 
asymptomatic infections for some parts or all of their life cycle. The host plants usually 
provide all of the essential nutrients (such as sucrose, amino acids, etc.,) to endophytes for 
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their survival.1 Endophytes are omnipresent across the plant kingdom (trees, plants, 
grasses, algae, etc.) and are commonly fungi and bacteria. Endophytes produce a range of 
biologically active compounds that may provide survival benefits to the host plants, such 
as protection against its natural enemies.2 Some strains of endophytic fungi only produce 
biologically active compounds in symbiosis, while others produce in both symbiosis and 
culture. The reasons for this dichotomy are still not understood.  
There needs to be a balanced interaction between the endophytes and host plants, 
and the interaction is usually maintained by the plant defense system. There are generally 
two balanced interactions: commensalism and mutualism. In commensalism, endophytes 
survive within the host on the nutrient supply, neither harming nor benefiting the host. On 
the contrary, mutualism is an interaction in which both of the organisms provide survival 
benefits to the other.3 Under certain conditions, the interaction may become parasitic, i.e., 
harmful for the host plant.4 
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Table 1.1. Summary of Epichloë spp. mediated resistances to multiple biotic and abiotic 
stresses. 
 
An increase in host plant resistance by the endophytes toward other enemies 
in a mutualistic relationship is called “acquired plant defense.”5 The host acquires 
defense against insects, herbivores, and a wide range of environmental conditions, 
such as drought and heat. A summary of Epichloë spp. mediated resistances to 
multiple biotic and abiotic stresses is given in Table 1.1.6 
Stress Endophyte-mediated response 
Drought tolerance Increase root growth; altered stomatal behavior and 
osmotic adjustments 
Nematode resistance Reduced nematode reproduction. 
 
Growth responses Phytohormones and synthetic growth hormones, 
increased phosphorous and mineral uptake, growth 
tolerance to low soil pH or high aluminum 
concentration, nitrogen use efficiency 
Interspecific competition Increased clonal growth and lateral spread; production 
of alleochemicals; increased seedling vigor and seed 
yield 
Disease resistance  Increased, decreased or no effect, depending on the 
system. 
 
Insect resistance  Peramine, lolines, ergot alkaloids 
Anti-herbivory of 
mammals 
Ergot alkaloids and indole-diterpenes 
Heat or low light intensity  Enhance tolerance. 
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Plants cannot protect themselves by moving away from an attack of their foe, nor 
are they blessed with immune systems like animals are. To cope with these problems, 
plants have developed defenses such as bark, thorns, etc. They also evolved to synthesize 
certain compounds or acquire them from an organism with which they have a symbiotic 
relationship. These compounds may act as antifeedants or precursors to physical defense 
tools. These compounds are called “secondary” or “specialized” metabolites.7 
This interaction between endophytes and host plants has been studied for a long 
time for its importance to agriculture. Some specialized metabolites produced by 
endophytes may cause problems to grazing livestock but can also possess anti-insect 
properties. It has been of great interest for the pastoral farming sector to find the endophyte 
strains that can synthesize compounds that have anti-insect activity but lack concomitant 
antimammalian activity.6 
Many types of specialized metabolites are produced by grass-associated 
endophytes. They help the grass to cope with numerous stress conditions such as drought, 
protection against vertebrates and invertebrates, and survival in poor soil conditions. The 
specialized metabolites discussed in this report are alkaloids that are produced by Epichloë 
species, which are groups of filamentous fungi that live as grass endophytes. Alkaloids 
produced by Epichloë spp. provide many benefits for the host grass. Some specialized 
metabolites produced by endophytes are ergovaline, aminopyrrolizidine, pyrolopyrazines, 
the indole-diterpenoids, and 11,12-epoxyjanthitrems (Figure 1.1) may be toxic to cattle and 
other livestock. The alkaloids are produced by different species of grasses infected with 
endophytes, but not every endophyte-grass association produces alkaloids.6 In this 
dissertation, I discuss the loline alkaloids that are produced by endophytic fungi of grasses.  
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Figure 1.1. Structure of ergovaline, pyrrolopyrazine, and 10-epi-11,12-epoxyjanthitrem. 
 
 Loline background 
In 1892, Hofmeister recognized an alkaloid with the elemental formula C7H12N2O 
and called it temuline.8 In 1955, Yunusov and Akramov isolated a related alkaloid from 
the Lolium temulentum (darnel) seeds and named it loline.9 In addition to loline and 
temuline, they also isolated other alkaloids, which they named N-acetylloline. In 1960, 
Yunusov and Akramov proposed the structure of loline with an exocyclic nitrogen and an 
oxygen attached to the same carbon (A) (Figure 1.2). 
 
Figure 1.2. Proposed structure of loline by Yunusov and Akramov in 1960. 
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In 1966, they proposed a new structure, N-methyl-1-endo-aminopyrrolizidine (B) 
(Figure 1.3).9 
 
Figure 1.3. Revised proposed structure of loline by Yunusov and Akramov in 1966. 
In 1965, Yates and Tookey proposed a structure for festucine that was the same as 
loline, but the N-methyl group was on the exo face (C) (Figure 1.4).   
 
Figure 1.4. Revised proposed structure of loline by Yates and Tookey in 1965. 
In 1969, Aasen and Culvenor showed that the structure of loline was identical to 
festucine. In 1972, Bates and Morehead established the absolute configuration of loline 
dihydrochloride by X-ray crystallographic analysis. The structure of loline is now regarded 
as having a pyrrolizidine nucleus with an ether linkage and containing both endocyclic and 
exocyclic nitrogen (C).9 In 1985, Dannhardt and Steindl reported that temuline and 
norloline were the same alkaloid.10 
Later on, various research groups isolated numerous types of lolines with different 
types of substituents (methyl, formyl, acetyl, propionyl, butyryl, isobutyryl, isovaleryl, and 
senecioyl) on the amino group. Some of the common lolines are shown in Figure 1.5.9 In 
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our work, the most relevant lolines have been norloline (NL), N-acetylnorloline (NANL), 
and N-formylloline (NFL). Until now, all evidence has suggested that these alkaloids are 
produced by fungal endophytes, not by the host plants.11  
 
Figure 1.5. Various naturally occurring loline alkaloids 
 
 Unusual features in loline structure 
Lolines have unusual molecular architectures for pyrrolizidine natural products. 
They have a tricyclic structure containing at least one heteroatom in every ring, and they 
have four contiguous stereocenters. The molecule is strained due to the presence of the 
ether bridge, which links two bridgehead C atoms, a very unusual context for a natural 
product. All but one of the carbon atoms in the pyrrolizidine ring are attached to a 
heteroatom. These features have caused scientists in detail to study the biosynthetic 
pathway leading to lolines.  
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  What have we learned in the past about the biosynthetic pathway of loline? 
Working together, our group and Dr. Schardl’s group were able to identify 
precursors and intermediates in loline alkaloid biosynthesis by feeding isotopically labeled 
substrates to a loline-producing culture of Epicoloë. uncinata and analyzing by GC-MS the 
isotopic content of the produced loline alkaloids (Scheme 1.5).12-13 These experiments 
showed that L-proline (Pro) and L-homoserine, likely in the form of O-acetylhomoserine 
(1),12 were the precursors whose carbon and nitrogen atoms were incorporated into the 
pyrrolizidine core, whereas L-methionine contributed the carbon atoms of the N-formyl 
and N-methyl substituents.12 The experiments also showed that compounds 2 and AP were 
likely intermediates in the biosynthetic pathway.13 
 
Scheme 1.5. Proposed biosynthetic pathway to lolines. 
We hypothesize that an enzyme encoded by the lolC gene catalyzes the -
substitution reaction between Pro and 1.12 LolC’s inferred amino acid sequence suggests 
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that is a -type pyridoxal-5´-phosphate (PLP) enzyme that is similar to the O-acetyl-
homoserine(thiol)-lyase encoded by the cysD gene of Aspergillus nidulans.14-15 O-
acetylhomoserine(thiol)-lyase catalyzes the -substitution of O-acetylhomoserine with H2S 
in methionine biosynthesis (Scheme 1.6).16,13 
 
Scheme 1.6. Comparison of reactions catalyzed by CysD and LolC. 
We hypothesize that the likely FAD-containing monooxygenase encoded by the 
lolF gene catalyzes the next step, oxidative decarboxylation of the pyrrolidine ring of 2 to 
give iminium ion 3.15 LolF is most closely similar to 1,2-cyclopentanone 
monooxygenase.
15, 17  
 
Scheme 1.7. Comparison of reactions catalyzed by cyclopentanone monooxygenase and 
LolF. 
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We further hypothesize that amino acid 3 undergoes decarboxylation catalyzed by 
the PLP enzyme encoded by the lolD gene to give amine 4 (Scheme 1.8).15 LolD’s amino 
acid sequence suggests that it is related to ornithine decarboxylase.15-16  
 
Scheme 1.8. Comparison of reaction catalyzed by ornithine decarboxylase and proposed 
to be catalyzed by LolD. 
We hypothesize that the PLP enzyme encoded by the lolT gene catalyzes 
cyclization of 4 to the known intermediate AP (Scheme 1.4).13, 15 LolT’s amino acid 
sequence suggests that it is closely related to isopenicillin N epimerase.15, 18  
 
Scheme 1.9. Comparison of reactions catalyzed by isopenicillin N epimerase and proposed 
to be catalyzed by LolT. 
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There are several different ways that the ether bridge could be introduced into AP 
(Scheme 1.5). Either C(2) or C(7) of AP could be hydroxylated to give intermediate 5 or 
6, respectively, and either intermediate 5 or 6 could then undergo cyclization to NL by C–
H activation of C(7) or C(2), respectively, followed by ring closure. Either a single or 
multiple enzymes could catalyze the hydroxylation and the cyclization.13 We previously 
hypothesized that these steps are catalyzed by the dioxygenase and oxidoreductase encoded 
by the lolO and lolE genes.15  
 Synthesis of pyrrolizidine core 
  
1.6.1. Christine et al. approach 
In 2000, Christine et al, published a racemic synthesis of AP.19 They initiated the 
synthesis by converting L-Pro to ethyl prolinate (7). N-Alkylation of 7 with ethyl acrylate 
formed the diester 8, which underwent Dieckmann cyclization, hydrolysis, and 
decarboxylation to produce ketone 9, presumably in racemic form due to epimerization 
under the decarboxylation conditions. This compound was converted to oxime 10 and then 
subjected to Raney Ni reduction to form two separable diastereomers, (±)-AP and (±)-1-
epi-AP (Scheme 1.10). 
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Scheme 1.10. Christine et al synthesis of (±)-AP. 
 
1.6.2. Giri et al. approach 
 
 
Scheme 1.11. Giri et al. synthesis of (–)-AP. 
In 2004, Giri et al. synthesized (–)-AP starting from prolinal 11.20 They converted 
11 to the sulfone 12 using the usual procedure, and reaction of 12 with enolate A formed 
amino ester 13 with syn:anti = 10:90. Selective reduction of the ester function in 13 with 
NaBH4 and CaCl2 produced alcohol 14. Removal of the Boc group in 14 and formation of 
a mesylate, which underwent intramolecular SN2 displacement in situ, resulted in the 
formation of bicyclic compound (–)-N-Cbz-AP. Removal of the Cbz group then gave 
enantiopure (–)-AP (Scheme 1.11).  
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1.6.3. Tang et al. approach 
In 2004, Tang et al. synthesized (+)-AP during the total synthesis of the natural 
product, (1S,8R)-(+)-absouline.21 Their synthesis began with chemoselective reduction of 
15 to give alcohol 16, which was subsequently treated with thiophenol to form sulfide 17. 
Nucleophilic reaction by allyl iodide produced 18. Treatment of 18 with BH3·SMe2 and 
subsequent oxidation with H2O2 under basic conditions resulted in the formation of alcohol 
19. Mesylation, acidification, and basification of 19 produced (+)-N-Cbz-AP. Compound 
(+)-N-Cbz-AP then underwent hydrogenolysis to form enantiopure (+)-AP·2HCl (Scheme 
1.12). 
 
 
Scheme 1.12. Tang et al synthesis of (+)-AP. 
 
1.6.4. Eklund et al. approach 
In 2012, Eklund et al. synthesized (–)-AP during the synthesis of (–)-absouline.22 
They started their synthesis with the reduction of 20 to give the corresponding aldehyde, 
which was subjected to Horner–Wadsworth–Emmons reaction to give 21a and 21b in 2:1 
ratio. Compound 21a underwent conjugate addition of an amine to give an inseparable 
mixture of 22a and 22b. The mixture of 22a and 22b was then converted into pyrrolizidines 
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23a and 23b, which were easily separated by chromatography. The compound 23b was 
then reduced with BH3·SMe2 and hydrogenolyzed to form (–)-AP·2HCl (Scheme 1.13).  
 
 
Scheme 1.13. Eklund et al approach to make pyrrolizidine ring. 
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Chapter 2. What happens if LolO expression is knocked down? 
 
(This chapter has been published as part of “Ether bridge formation in loline alkaloid 
biosynthesis” by Juan Pan, Minakshi Bhardwaj, Jerome R. Faulkner, Padmaja Nagabhyru, 
Nikki D. Charlton, Richard M. Higashi, Anne-Frances Miller, Carolyn A. Young, Robert 
B. Grossman, Christopher L. Schardl.23 This chapter’s experimental section reports only 
the work done by me.) 
 
 Introduction: 
In 2008, Dr. Jerome Faulkner observed the accumulation of an unknown metabolite 
in the culture of E. uncinata after he used RNAi to knock down expression of the lolO 
gene.16 Dr. Juan Pan later isolated the metabolite and tentatively identified it as AcAP 
(Figure 2.1).23 Dr. Pan also observed that several Epichloë species (such as Epichloë. 
amarillans strains E721, E722 and E862, Epichloë. brachyelytri E4804, and Epichloë. 
canadensis e4814)23 with lolO mutations accumulated the same compound but did not 
produce loline alkaloids. These observations suggested that the compound was an 
intermediate in the biosynthetic pathway leading to loline alkaloids.  
 
Figure 2.1. (±)-1-exo-Acetamidopyrrolizidine (AcAP) and its numbering scheme. 
Dr. Juan Pan isolated enough of the new metabolite, which I used to determine its 
formula and connectivity by MS and NMR, but NMR experiments to assign its 
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stereochemistry gave ambiguous results. I decided to prepare AcAP synthetically in order 
to compare its structure with that of the new metabolite and establish the structure of the 
latter, including its stereochemistry, with certainty.  
 Results and discussion 
 
2.2.1. Synthesis of ()-AcAP and ()-1-epi-AcAP 
To make AcAP, I adapted (Scheme 2.1) the procedure for synthesis of AP 
developed by Christine et al. (Scheme 1.10).19 Christine et al. used NaOMe as a base for 
Dieckmann cyclization to cyclize diester 8, but I found that when I used LDA as a base, 
our yield was higher than the reported yield.19 Hydrolysis, decarboxylation, and oxime 
formation then gave (±)-10. I reduced (±)-10 with Raney Ni in THF to give AP along with 
some 1-epi-AP, and allowed this mixture to react with Ac2O and DMAP to afford (±)-
AcAP in 8% yield over the two steps. The 1-epi-AP was not observed to react with Ac2O 
under these conditions. By contrast, when I reduced (±)-10 with Pd/C/H2, I observed (±)-
1-epi-AcAP only. 
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Scheme 2.1. Synthetic scheme to make (±)-AcAP and (±)-1-epi-AcAP. 
 
2.2.2. HRMS and NMR analysis of synthetic ()-AcAP 
The fact that only one of the diastereomers obtained from the Raney Ni reduction 
reacted further with Ac2O made us confident that our AcAP had exo stereochemistry, but 
I wanted to establish the stereochemistry of our presumed (±)-AcAP with absolute 
certainty. Therefore, I analyzed its structure and stereochemistry with NMR and HRMS.  
HRMS (Figure A.1) revealed that synthetic (±)-AcAP showed an [M + H] peak 
with the molecular formula C9H17N2O. The HSQC spectrum (Figure 2.2) confirmed the 
presence of 15 H atoms: two methine groups, five pairs of methylene groups, and one 
methyl group.  
The HSQC spectrum (Figure 2.2) showed that the two most downfield protons, at 
4.12 and 3.26 ppm, were due to the methine H atoms at C(1) and C(8). Due to the greater 
electronegativity of the amido functional group, I assigned the most downfield resonance 
to the C(1) H atom. The HMBC spectrum (Figure A.2) supported this assignment, as there 
was a correlation between the 1H NMR resonance at 4.12 ppm and the 13C NMR resonance 
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due to C(10), a three-bond coupling (Figure 2.3). By contrast, there was no correlation in 
the HMBC spectrum between the 1H NMR resonance at 3.26 ppm and the 13C NMR 
resonance due to C(10).  
 
Figure 2.2. 600 MHz 1H–13C HSQC NMR spectrum of ()-AcAP. 
 
Figure 2.3. HMBC correlations between H atom at C(1) and acetyl group of AcAP. 
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Figure 2.4. 600 MHz 1H–1H COSY NMR spectrum of (±)-AcAP.  
I assigned the remainder of the resonances to H atoms on the basis of chemical 
shifts and 1H-1H COSY correlations (Figure 2.4). The next most downfield resonance after 
the C(1) proton was at 3.22 ppm, which could have been one of the C(3) protons, as it was 
nearer to two N atoms as compared to others. I inferred from the HSQC spectrum that the 
H atom resonating at 3.22 ppm was geminal to the H atom resonating at 2.61 ppm, 
suggesting that these two resonances were due to the two H atoms at C(3). The resonance 
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at 3.03 ppm could have been due to an H atom at C(5), as it was near to a N atom, and 
HSQC showed that it was geminal to the H atom resonating at 2.61 ppm. COSY showed 
the strongest correlation between the C(1) and C(8) H atoms and strong correlation between 
the C(1) H atom and H atoms resonating at 1.73 ppm and 2.16 ppm, which HSQC showed 
were a geminal pair (Figure 2.5). These data suggested that the H atoms resonating at 1.73 
ppm and 2.16 ppm were at C(2). There was also a strong correlation in the COSY spectrum 
between the C(2) resonances and those assigned to C(3), which supported the initial 
assignment of the latter resonances.  
 
Figure 2.5. COSY correlations between H atoms at C(1), C(2), C(3) and C(8) of AcAP. 
In the COSY spectrum of AcAP, there was a strong correlation between the 
resonance arising from the C(8) H atom and the resonances at 2.16 ppm and 1.60 ppm, 
which HSQC showed were a geminal pair, suggesting that they could be assigned to the H 
atoms at C(7) (Figure 2.6). 
 
Figure 2.6. COSY correlations between H atoms at C(1), C(7) and C(8) of AcAP. 
The remaining resonances at 1.73 ppm and 1.83 ppm, which HSQC showed were 
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a geminal pair, showed strong correlations in the COSY spectrum with the resonances 
arising from the C(7) and C(5) H atoms. These data suggested that these last two resonances 
could be assigned to the H atoms at C(6) (Figure 2.7). The resonances at C(6) also showed 
a strong correlation with the resonances that had previously been assigned to the C(5) H 
atoms, further supporting our initial assignments.  
 
Figure 2.7. COSY correlations between H atoms at C(6) and C(7) and between H atoms 
at C(5) and C(6) of AcAP. 
2.2.3. HRMS and NMR analysis of ()-1-epi-AcAP  
Meanwhile, I was able to synthesize ()-1-epi-AcAP through the reduction of (±)-
10 with Pd/C/H2 (Scheme 2.1). The HRMS spectrum of ()-1-epi-AcAP (Figure A.3)  was 
similar to ()-AcAP, as expected for these diastereomers. The HSQC spectrum of ()-1-
epi-AcAP (Figure 2.8) showed the presence of the same numbers of methine groups (two), 
methylene groups (five), and methyl groups (one) as its diastereomer. 
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Figure 2.8. 400 MHz 1H–13C HSQC NMR spectrum of ()-1-epi-AcAP. 
The two downfield resonances in the HSQC spectrum of compound ()-1-epi-
AcAP were methine H atoms, one at 4.41 ppm and the other at 3.84 ppm. I assigned the 
4.41 ppm resonance to the H atom at C(1) due to its close proximity to an amido group. 
The only remaining methine H atom in the structure was at C(8), allowing us to assign the 
resonance at 3.84 ppm to it. I allotted the chemical shifts of the remaining protons with the 
help of the COSY spectrum (Figure 2.9).  
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Figure 2.9. 400 MHz 1H–1H COSY NMR spectrum of ()-1-epi-AcAP. 
The resonances that I attributed to the H atoms at C(1) and N(9) showed a strong 
correlation in the COSY spectrum (Figure 2.10), which further supported our assignment 
of the C(1) H atom. The COSY spectrum showed no correlation between the resonances 
that I attributed to the H atoms at C(8) and N(9).  
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Figure 2.10. COSY correlation between H atoms at C(1) and N(9) of 1-epi-AcAP.  
There was a strong correlation in the COSY spectrum between the resonance due 
to the H atom at C(1) and resonances at 2.07 ppm and 1.69 ppm (Figure 2.11), which the 
HSQC spectrum showed arose from a geminal pair. These data suggested that these 
resonances were due to the two H atoms at C(2).  
 
Figure 2.11. COSY correlations between H atoms at C(1) and C(2) of 1-epi-AcAP. 
The resonance due to the H atom at C(8) showed a correlation in the COSY 
spectrum with resonances at 1.69 ppm and 1.38 ppm (Figure 2.12), which the HSQC 
spectrum showed arose from a geminal pair. These data suggested that these resonances 
were due to the two H atoms at C(7). 
 
Figure 2.12. COSY correlations between H atoms at C(7) and C(8) of 1-epi-AcAP. 
After the resonances due to the H atoms at C(1) and C(8), the next most downfield 
resonance in the 1H NMR spectrum of ()-1-epi-AcAP was at 3.22 ppm. This resonance 
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could have arisen from an H atom at C(3) or one at C(5), as these H atoms were closest to 
N as compared to the rest of the unassigned H atoms. In the HSQC spectrum, the resonance 
at 2.85 ppm showed a geminal relationship with the resonance at 3.22 ppm. I assigned these 
two resonances to the H atoms at C(3) due to their greater proximity to two electronegative 
N atoms. This assignment then suggested that the remaining resonances at 3.22 ppm and 
2.64 ppm, which the HSQC spectrum showed arose from geminal H atoms, should arise 
from the H atoms at C(5).  
The only unassigned H atoms left in ()-1-epi-AcAP were those at C(6). In the 
COSY spectrum, the resonances that arose from the H atoms at C(5) and C(7) showed a 
strong correlation with overlapping resonances at 1.79 ppm (Figure 2.13), which the HSQC 
spectrum showed arose from a geminal pair. These data suggested that these resonances 
arose from the H atoms at C(6). 
 
Figure 2.13. COSY correlations between protons at, (A) C(6) and C(7); and (B) C(6) and 
C(5) of 1-epi-AcAP. 
2.2.4. NMR analysis of stereochemistry of ()-AcAP and ()-1-epi-AcAP 
The COSY and HSQC NMR spectra helped us to assign the structures of both 
diastereomers ()-AcAP and 1-epi-AcAP, but the relative stereochemistry of the H atoms 
at C(1) and C(8) in the two diastereomers could not be determined until I considered 
NOESY correlations (Figures 2.14 and 2.15).  
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Figure 2.14. 400 MHz 1H–1H NOESY NMR spectrum of (±)-AcAP. 
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Figure 2.15. 400 MHz 1H–1H NOESY NMR spectrum of ()-1-epi-AcAP. 
 
To unambiguously establish the stereochemistry of C(1) relative to C(8) in (±)-
AcAP and ()-1-epi-AcAP, I looked for NOE interactions between the H atoms at N(9) 
and C(1); N(9) and C(8); C(1) and C(7); and C(1) and C(8). In the NOESY spectrum of 
(±)-AcAP, I observed correlations between one of the H atoms at C(7) and the H atom at 
C(1), and between the H atoms at N(9) and C(8) (Figure 2.16). These correlations were 
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only possible in (±)-AcAP if the H atom at C(1) was trans with respect to the ring fusion 
H atom at C(8). I did not observe these interactions in the NOESY spectrum of ()-1-epi-
AcAP, but I did observe correlations between the H atoms at C(1) and C(8), and between 
the H atoms at C(1) and N(9) (Figure 2.17). These data strongly suggested that (±)-AcAP 
was the exo isomer, and ()-1-epi-AcAP was the endo isomer.  
However, I found a correlation in the NOESY spectrum of (±)-AcAP that was 
difficult to explain with our assignment. The correlation was between the resonances due 
to the H atom at C(1) and the resonance due to H atoms at C(8) and C(3). If the correlation 
was to the H atom at C(8), it could be rationalized as being due to hopping (transfer of 
energy from one atom to another) or COSY leakage. If the correlation was to the H atom 
at C(3), it could be a transannular NOE. It was hard to distinguish between these 
possibilities. 
 
Figure 2.16. 1H–1H NOESY correlations between H atoms at C(1) and C(7), and C(8) 
and N(9) in (±)-AcAP. 
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Figure 2.17. 1H–1H NOESY correlations between H atoms at C(1) and C(8), and C(1) 
and N(9) in (±)-1-epi-AcAP. 
2.2.5. Crystal structure of synthetic ()-AcAP 
I was able to grow crystals of (±)-AcAP from CHCl3 that were suitable for analysis 
by X-ray crystallography, which allowed me to assign its stereochemistry unequivocally. 
The crystals that I obtained were centrosymmetric, with each unit cell containing a single 
complex consisting of a 2:1 ratio of (±)-AcAP to HCl (Figure 2.18). In this complex, the 
ring N atoms of the two molecules of (±)-AcAP formed a linear N–H+–N arrangement, and 
the two amide N-H groups coordinated to Cl–. There was a very short intramolecular N-H-
N bond (2.632 Å) in the crystal, which is rare but not unique for this type of compound.24-
26 In any case, the crystal structure clearly showed that the stereochemistry of the amido 
group at C(1) of (±)-AcAP was exo with respect to the C(8) H atom, further supporting the 
structure determined by NMR.  
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Figure 2.18 ORTEP diagram of 2AcAP·HCl. 
 
2.2.6. NMR and MS spectra of mixture of synthetic (±)-AcAP and isolated 
metabolite were identical to those of individual samples 
In order to determine whether synthetic (±)-AcAP was identical to putative isolated 
AcAP, I mixed equimolar samples of the two materials in CDCl3, and I analyzed the 
mixture by 1H NMR (Figure A.4) and 13C NMR (Figure A.5). There were no changes from 
the NMR spectra of isolated and synthetic (±)-AcAP to the NMR spectra of the mixed 
material. The GC–MS spectrum of the equimolar mixture was also indistinguishable from 
the GC–MS spectra of the individual compounds (Figure A.6). These analyses established 
that the new metabolite had a structure and stereochemistry identical to synthetic (±)-
AcAP, with the caveat, of course, that the isolated AcAP was almost certainly 
enantiomerically pure.  
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 Conclusion 
I have shown that AcAP is a novel metabolite that can be isolated from fungi that 
have a mutated lolO gene. The natural conclusion is that AcAP is the substrate for LolO in 
the loline biosynthetic pathway. However, there is also the possibility that AP, a known 
intermediate, is the actual substrate of LolO, and that AcAP forms by reaction of AP with 
an endogenous acetylase only when AP begins to accumulate because functional LolO is 
absent. In other words, AcAP could be a shunt product, and may not be involved in the 
biosynthesis of loline at all. In the following chapter, I will investigate whether AcAP is a 
real intermediate or a shunt product. 
 Experimental Section 
Ethyl (2S)-N-(3-ethoxy-3-oxopropyl)prolinate (8) 
  
Ethyl L-prolinate (7) (10.0 g, 69.8 mmol) and ethyl acrylate (34.9 g, 349 mmol) were added 
to the reaction vessel and were heated to reflux under nitrogen for 24 h. The reaction 
mixture was allowed to come to RT, and excess ethyl acrylate was evaporated. It was 
poured onto a silica column, then eluted with ethyl acetate:petroleum ether (4:6). The 
solvent was evaporated to yield 16.9 g (98%, 69.5 mmol) of 8. 1H NMR (400 MHz, 
CDCl3):  4.14 (q, 7.2 Hz, 2H), 4.09 (q, 7.2 Hz, 2H), 3.12 (ddt, Jd = 19.8 Hz, Jd = 8.1 Hz, 
Jt = 4.2 Hz, 2H), 2.99 (dt, Jd = 12.2 Hz, Jt = 7.7 Hz, 1H), 2.70 (dt, Jd =12.2 Hz, Jt = 7.5 
Hz, 1H), 2.48 (t, 7.6 Hz, 2H), 2.37 (q, 8.0 Hz, 1H), 2.12-1.97 (m, 1H), 1.96-1.68 (m, 3H), 
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1.23 (t, 7.1 Hz, 3H), 1.20 (t, 7.2 Hz, 3 H). 13C NMR (100 MHz, CDCl3):  14.3, 14.4, 23.3, 
29.5, 34.0, 50.0, 53.4, 60.5, 60.7, 65.9, 172.4, 174.2. IR (ATR): 1729 cm-1. 
 
(±)-1-Oximinopyrrolizidine ((±)-10) 
 
A solution of n-BuLi (18.1 mL, 2.27 M) in hexane was added to a solution of 
diisopropylamine (6.81 mL) in dry THF (225 mL) at –78 C. The reaction mixture was 
stirred for 1 h. A solution of 8 (5.00 g, 20.6 mmol) in THF was prepared and added to the 
above reaction mixture. The reaction mixture was stirred at –78 C for 2 h and then brought 
to RT. Water (30.0 mL) was added to it, and the mixture was concentrated by evaporation 
of THF. The reaction mixture was cooled to 0 C. Conc. HCl (30 mL) was added to it drop-
by-drop, and the mixture was heated to reflux for 1.5 h. The reaction mixture was adjusted 
to pH 9 by adding a saturated solution of K2CO3 at 0 C. NH4OH·HCl (1.43 g, 20.6 mmol) 
was added, and the mixture was heated to reflux for 2 h. The mixture was then left to stir 
for 24 h. The crude compound was extracted with continuous extraction for 3 days with 
CH2Cl2. The solvent was concentrated and poured onto a silica column, and then eluted 
with CH2Cl2:CH3OH:NH4OH (8:2:0.2). Solvent was evaporated to yield 1.07 g (37%, 7.6 
mmol) of (±)-10 as a light brown powder that consisted of an inseparable mixture of 
diastereomers. 1H NMR (400 MHz, CD3OD):  4.09 (t, 7.7 Hz, 1H, minor), 3.82 (dd, 8.2 
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Hz, 3.6 Hz, 1H, major), 3.19-2.85 (m, 6H, minor), 2.84-2.47 (m, 6H, major), 2.37-2.23 (m, 
1H, major), 2.21-2.05 (m, 1H, minor), 2.00-1.70 (m, 3H). 13C NMR (100 MHz, CD3OD): 
 (major) 25.9, 30.3, 30.9, 51.0, 54.13, 62.8, 161.2;  (minor) 25.9, 30.2, 30.9, 51.6, 54.1, 
66.5, 165.9. IR (ATR): 3201, 1738, 1676 cm-1. 
(±)-1-exo-Acetamidopyrrolizidine ((±)-AcAP) 
 
Compound (±)-10 (0.29 g, 2.09 mmol) was dissolved in THF, and Raney Ni (in excess) 
was added to it. The mixture was stirred for 13 h at RT as indicated by TLC for completion 
of reduction to amine. Acetic anhydride (0.196 mL, 2.08 mmol) and DMAP (0.254 g, 2.08 
mmol) were added to the reaction mixture, which was stirred at RT for 2 h. It was filtered 
through a short bed of Celite, followed by dilution with CHCl3. The pH of the solution was 
adjusted to 12 by adding 1 M NaOH, followed by an addition of saturated NaHCO3 and 
brine. The phases were allowed to separate for 30 min, and the aqueous layer was extracted 
with CHCl3 twice. The organic layers were combined and dried over MgSO4, filtered, and 
concentrated. The residue was poured onto a silica column, then eluted with 
CH2Cl2:CH3OH:NH4OH (6:4:1.5). Solvent was evaporated to yield 29 mg (8%, 0.17 
mmol) of (±)-AcAP as white crystalline solid, mp 72-74 C. 1H NMR (400 MHz, CDCl3): 
 1.63 (dq, Jd = 6.8 Hz, Jq = 13.2 Hz,  1H), 1.68-1.78 (m, 2H), 1.79-1.85 (m, 1H), 1.93 (s, 
3H), 1.99 (dq, Jd = 7.0 Hz, Jq = 13.0 Hz, 1H), 2.16 (dq, Jd = 6.4 Hz, Jq = 12.6 Hz, 1H), 
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2.62 (dq, Jd = 10.7 Hz, Jq = 7.0 Hz, 2H), 3.07 (dt, Jd = 10.7 Hz, Jt = 6.4 Hz, 1H), 3.29 (dt, 
Jd = 11.3 Hz, Jt = 6.4 Hz, 1H), 3.35 (dt, Jd = 12.6 Hz, Jt = 6.4 Hz, 1H) 4.2 (app. quint., 6.4 
Hz, 1H), 6.64 (broad d, 5.9 Hz, 1H). 13C NMR (100 MHz, CDCl3):  23.6, 25.6, 30.8, 
33.0, 53.5, 55.4, 55.5, 71.0, 170.1. IR (ATR): 3272, 1649, 1554 cm-1. HRMS: m/z calcd 
for C9H17ON2 (M + H): 169.1341; found: 169.1336.  
 
(±)-1-endo-Acetamidopyrrolizidine ((±)-1-epi-AcAP) 
 
Compound 10 (0.10 g, 0.73 mmol) was dissolved in THF and palladium charcoal (0.22 g) 
was added to it and hydrogenated with a H2 balloon. The reaction mixture was stirred 
overnight at RT as indicated by TLC for completion of reduction to amine. Acetic 
anhydride (0.06 mL, 0.73 mmol) was added and stirred at RT for 2 h. The reaction mixture 
was filtered through a short bed of Celite, followed by dilution with CHCl3. The pH of the 
solution was adjusted to 12 by adding 1 M NaOH, followed by addition of saturated 
NaHCO3 and brine. The phases were allowed to separate for 30 min and aqueous layer was 
extracted with CHCl3 twice. The organic layers were combined and dried over MgSO4. It 
was filtered and concentrated. The residue was poured onto a silica column and eluted with 
CH2Cl2:CH3OH:NH4OH (6:4:1.5). Solvent was evaporated to yield 12.7 mg (10%, 0.08 
mmol) of (±)-1-epi-AcAP as yellow solid. 1H NMR (400 MHz, CDCl3):  5.51 (s, 1H), 
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4.36 (dddd, 7.6 Hz, 6.6 Hz, 6.4 Hz, 6.3 Hz, 1H), 3.62 (q, 7.3 Hz, 1H), 3.05 (dt, Jd = 10.9 
Hz, Jt = 6.4 Hz, 2H), 2.55 (dt, Jd = 10.8 Hz, Jt =6.9 Hz, 1H), 2.45 (ddd, 10.0 Hz, 8.2 Hz, 
6.6 Hz, 1H), 2.07 (dq, Jd = 13.4 Hz, Jq = 6.8 Hz, 1H), 1.94 (s, 3H), 1.85-1.60 (m, 4H), 1.39 
(dq, Jd = 12.5 Hz, Jq = 8.3 Hz, 1H); 
13C NMR (100 MHz, CDCl3):  23.6, 25.6, 30.5, 32.6, 
53.5, 54.8, 55.4, 71.6, 170.2; IR (ATR): 3258, 1667, 1547 cm-1. HRMS: m/z calcd for 
C9H17ON2 (M + H): 169.1341; found: 169.1333 
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Chapter 3. Is AcAP a shunt product or a substrate for LolO? 
 
 
(This chapter has been published as part of “Enzymes from Fungal and Plant Origin 
Required for Chemical Diversification of Insecticidal Loline Alkaloids in Grass-Epichloë 
Symbiota” by Juan Pan, Minakshi Bhardwaj, Padmaja Nagabhyru, Robert B. Grossman, 
Christopher L. Schardl.27 This chapter’s experimental section reports only the work done 
by me.) 
 
 Introduction 
The lolO gene belongs to the genome of loline-producing fungi.23 A homology 
search of the genome sequence of various enzymes shows that LolO is a mononuclear non-
heme iron oxygenase enzyme.27 LolO belongs to the superfamily of alpha-ketoglutarate 
dependent enzymes.27 Enzymes of this family are known to catalyze a wide variety of 
reactions, such as halogenation, hydroxylation, H-atom abstraction via C–H bond 
activation, oxidative ring closure, desaturation, oxidative aromatic ring cleavage, and C=C 
double bond epoxidation.28-29 Such enzymes play an important role in the biosynthesis of 
antibacterial agents, neurotransmitters, and other metabolites.30 
I discussed the new metabolite, AcAP in chapter 2, where I was able to establish 
the structure and stereochemistry of AcAP by comparing it with synthetic (±)-AcAP. In 
the present chapter, I will explore whether AcAP is a shunt product or a natural substrate 
of LolO.23  
There were two possible explanations (Scheme 3.1) for the accumulation of AcAP 
when lolO was either mutated or subjected to RNAi. Our favored explanation was that 
AcAP was an intermediate in the loline biosynthesis pathway, and that lolO catalyzed 
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oxidative ether bridge formation on AcAP to make NANL (Scheme 3.1, Pathway A). The 
hypothesis that AcAP was the intermediate could be explained by the reason that the 
oxidative C–H bond activations catalyzed by LolO might go more smoothly in the presence 
of the amide group of AcAP as compared to the more easily oxidized primary amino group 
of AP. The other explanation was that AP was the intermediate and lolO catalyzed the 
oxidative ether bridge formation on AP, resulting in the formation of NL as the first 
tricyclic loline in the biosynthetic pathway. NL would then undergo acetylation to make 
NANL (Scheme 3.1, Pathway B). If the latter hypothesis were true, then AcAP would be 
only a shunt product, the result of an endogenous enzyme acting on AP accumulating in 
the absence of LolO.23  
 
Scheme 3.1. Alternative pathways that might explain accumulation of AcAP. Pathway A: 
AcAP is an intermediate in loline biosynthesis. Pathway B: AcAP is a shunt product.  
In order to determine which hypothesis was correct, we decided to feed (±)-AcAP 
that had a D atom in both the ring and the acetyl group to loline-producing culture. This 
experiment would allow us to determine which pathway the loline biosynthesis took. If 
AcAP were the intermediate (Scheme 3.1, Pathway A), then the product NANL would 
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retained all of the D. However, if AcAP were a shunt product (Scheme 3.1, Pathway B), 
then any AcAP that converted to NANL would first have to be hydrolyzed to AP by 
removal of the deuterated acetyl group, and hence the NANL would retain only D from the 
ring.23 
 Results and discussion 
 
3.2.1. Synthesis of 2´,2´,2´,3-[2H4]-AcAP 
To distinguish which of the two pathways (Scheme 3.1, A and B) was operative, I 
decided to synthesis (±)-AcAP that was labeled both in the pyrrolizidine ring and on the 
acetyl group, which could be feed to loline-producing fungus in culture. My predecessor, 
Dr. Hussaini, had previously prepared (±)-3,3-[2H2]-AP by replacing ethyl acrylate with 
ethyl 3,3-[2H2]-acrylate in the Christine et al. procedure (Scheme 1.10).
13 Adapting this 
protocol, I prepared (+)-3,3-[2H2]-10, reduced it with Raney Ni in THF, and allowed the 
product to react with acetic anhydride-d6 (Scheme 3.2). Sadly, the MS analysis of the 
resulting AcAP showed that it consisted of about 85% tetradeuterated AcAP, 13% 
trideuterated AcAP, and only trace amounts of desired pentadeuterated AcAP. The 1H 
NMR spectrum of the material showed the presence of H atoms at the C(3) position, rather 
than being fully deuterated as hoped. These results implied that Raney Ni must have 
catalyzed the substitution of D with H. It may have been that Dr. Hussaini did not see as 
much scrambling of D with H in our past syntheses of AP because he ran the reduction in 
isopropanol, whereas I used THF. It is also possible that the Raney Ni that he used in his 
reactions was less active than what I used.  
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Scheme 3.2. Synthesis of 2´,2´,2´,3-[2H4]-AcAP.
 
Even though I lost one of the two D atoms from the pyrrolizidine ring, the fact that 
one D atom was still present there in 85% of the material allowed us to move forward with 
the feeding experiment with loline-producing culture.   
3.2.2. Production of [2H4]-NANL upon feeding ()-2´,2´,2´,3-[
2H4]-AcAP to loline-
producing culture 
Dr. Juan Pan fed synthetic ()-2´,2´,2´,3-[2H4]-AcAP to loline-producing culture 
of E. uncinata, e167. The GC-MS of the NANL that was produced showed peaks at m/z = 
183 and m/z = 187 (Figure 3.1C). We knew that the 183 peak was due to NANL that was 
produced from naturally produced AcAP (Figure 3.2b), so it seemed likely that the 187 
peak was due to [2H4]-NANL that was produced from the added [
2H4]-AcAP. We 
concluded that AcAP was indeed an intermediate in loline alkaloid biosynthesis, acting as 
the substrate for LolO.27  
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Figure 3.1. (A) GC-MS total ion chromatogram of feeding of 2´,2´,2´,3-[2H4]-AcAP to 
loline-producing culture; (B) mass spectrum showing undeuterated NANL at retention time 
of 13.948 min; (C) mass spectrum showing incorporation of deuterium in NANL at 
retention time of 13.921 min.27 (Figure by Dr. Juan Pan.) 
 Conclusion 
We have established that acetylation occurs before ether bridge formation (Scheme 
3.1, Pathway A), that AcAP is the substrate of LolO, and that NANL is the first loline 
alkaloid in the biosynthetic pathway. It follows that all the loline alkaloids thereafter are 
derived from NANL through various modifications of substituents on the exocyclic N atom 
in NANL. However, these data do not tell us what is the product of LolO acting on AcAP. 
I will investigate this interesting question in more detail in Chapter 4.  
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 Experimental Section 
 
Ethyl (2S)-N-(3-ethoxy-3-oxo-1,1-dideuteropropyl)prolinate (1´,1´-[2H2]-8) 
 
  
A solution of ethyl triphenylphosphonoacetate (25.0 g, 71.8 mmol) in dry acetonitrile (126 
mL) was warmed to 50 C under nitrogen. Paraformaldehyde-d2 (2.29 g, 71.8 mmol) was 
added to it, and the mixture was stirred for 16 h at 50 C. The reaction mixture was allowed 
to come to RT, PPh3 (2.26 g, 8.61 mmol, 12 mol %) and 7 (10.3 g, 71.8 mmol) were added, 
and the mixture was heated to reflux under nitrogen for 24 h. The reaction mixture was 
allowed to come to RT and stirred for 48 h. The reaction mixture was concentrated and 
poured onto a silica column and eluted with ethyl acetate:petroleum ether (4:6). The 
solvents were evaporated to yield 14.3 g (81%, 58.3 mmol) of 1´,1´-[2H2]-8 as a yellow oil 
. 1H NMR (400 MHz, CDCl3):  4.22-4.00 (m, 4H), 3.23-3.03 (m, 2H), 2.45 (s, 2H), 2.38 
(q, 8.0 Hz, 1H), 2.19-2.03 (m, 1H), 1.97-1.69 (m, 3H), 1.33-1.16 (m, 6H). 2H NMR (61.5 
MHz, CDCl3):  2.96 (broad s, 1H), 2.68 (broad s, 1H). 
13C NMR (100 MHz, CDCl3):  
14.3, 14.4, 21.3, 23.3, 49.2 (quintet, 21.1 Hz), 53.3, 60.5, 60.8, 65.9, 172.4, 174.1. 
 
(±)-3,3-Dideutero-1-oximinopyrrolizidine ((±)-3,3-[2H2]-10) 
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This procedure was same as for the synthesis of (±)-10. We obtained (±)-3,3-[2H2]-10 (900 
mg g, 6.36 mmol, 31%) as a mixture of inseparable diastereomers and as a light brown 
powder. 1H NMR (400 MHz, CD3OD):  4.08 (t, 7.6 Hz, 1H, minor), 3.81 (dd, 8.1 Hz, 3.5 
Hz, 1H, major), 2.99 (dq, Jd = 7.9 Hz, Jq = 4.7 Hz, 1H), 2.84-2.40 (m, 3H), 2.38-2.06 (m, 
1H), 1.99-1.65 (m, 4H). 2H NMR (61.5 MHz, CDCl3 with CD3OD as impurity):  3.04 
(broad s, 1H), 2.75 (broad s, 1H). 13C NMR (100 MHz, CD3OD):  (major) 26.1, 26.3, 
31.1, 54.2, 64.5, 166.2, NCD2 not observed.  (minor) 26.4, 29.1, 30.3, 54.5, 63.0, 166.3, 
NCD2 not observed, IR (ATR): 3206, 2207-2106, 1673 cm
-1. 
(±)-1-exo-(2,2,2-Trideuteroacetamido)-3-deuteropyrrolizidine (()-2´,2´,2´,3-[2H4]-
AcAP) 
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The procedure was same as for the synthesis of (±)-AcAP, but instead of acetic anhydride, 
acetic anhydride-d6 was used, affording 31.1 mg (8%, 0.18 mmol) of mostly ()-2´,2´,2´,3-
[2H4]-AcAP as a yellow solid, with the major impurity being ()-2´,2´,2´-[
2H3]-AcAP. 
1H 
NMR (400 MHz, CDCl3):  1.61 (dq, Jd = 12.9 Hz, Jq = 6.9 Hz, 1H), 1.71 (dq, Jd = 12.9 
Hz, Jq = 6.9 Hz, 2H), 1.81 (m, 1H), 1.95 (dq, Jd = 12.9 Hz, Jq = 6.9 Hz, 1H), 2.14 (~quintet, 
5.9 Hz, 1H), 2.59 (broad s, 1H), 3.00 (broad s, 1H), 3.22 (broad d, 2H), 4.08 (~quintet, 6.9 
Hz, 1H), 6.52 (broad d, 5.2 Hz, 1H). 2H NMR (61.5 MHz, CDCl3):  1.89 (broad s, 6H), 
2.60 (broad s, 1H); 13C NMR (100 MHz, CDCl3):  22.8 (m), 25.5, 30.8, 32.8, 53.2 (m), 
55.3, 55.4, 70.8, 170.3. IR (ATR): 3438, 2254, 1652 cm-1. HRMS: m/z calcd for 
C9H13D4N2O (M+H): 173.1594; found: 173.1586.  
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Chapter 4. What is the product of LolO acting on AcAP? 
(Experiments for this chapter is reported in chapter 2)  
 
 Introduction 
We have established that AcAP is the substrate acted upon by LolO, but we do not 
know whether LolO oxidizes AcAP alone or with the help of other oxidizing enzymes 
produced by the fungus. Four oxygenase enzymes (LolF, LolP, LolO and LolE) are 
encoded in the LOL gene cluster. Previous studies have established that LolP catalyzes 
oxidation of NML to NFL (Scheme 1.5) and is not involved in the biosynthetic pathway of 
loline until after the formation of the first tricyclic loline.23 LolF, identified as an FAD 
monooxygenase, has been proposed to catalyze the oxidative decarboxylation of 
pyrrolidine ring to iminium ion 5 (discussed in Chapter 1, Scheme 1.5)27 because the FAD 
cofactor does not have enough oxidative potential to catalyze one of the C–H oxidations 
necessary for ether bridge formation in AcAP. Therefore, LolE and LolO are the only 
strong candidates for the installation of the ether bridge into AcAP.23 Moreover, it is 
possible that LolO is catalyzing the hydroxylation of AcAP and that LolE is catalyzing the 
subsequent ether bridge formation to make NANL, but it is also possible that LolO is 
catalyzing both the oxidizing steps to make NANL, and LolE is not involved at all in the 
process.23 
To clarify the roles of LolO and LolE in ether bridge formation, we can feed (±)-
AcAP to a medium that contains LolO but not LolE. Two experiments that would 
accomplish this goal are: (1) feeding synthetic AcAP to yeast into which lolO has been 
cloned; and (2) feeding synthetic AcAP to purified LolO in vitro.  
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Formation of ether bridge by single Fe/2-OG oxygenase (2-OG is 2-oxoglutarate) 
through activations of two C–H bonds are rare but precedented. Only three enzymes, 
clavaminic acid synthase (CAS), hyoscyamine 6β-hydroxylase (H6H), and AurH, a 
cytochrome P450 monooxygenase are known to perform two C–H bond activations and 
form a new oxacycle. 
CAS, a 2-OG-dependent enzyme, catalyzes the key bond-forming step in the 
clavulanic acid biosynthesis (Scheme 4.1). Clavulanic acid is a -lactam drug and is widely 
used to inhibit serine -lactamases.31 CAS performs hydroxylation, oxidative bicyclization, 
and desaturation.31-32 It is highly unusual for a single enzyme to do three transformations, 
with two of those being C–H bond oxidations. 
 
Scheme 4.1. C–H bond activation in clavunic acid biosynthesis. 
H6H, another 2-OG-dependent enzyme, catalyzes the epoxidation of hyoscyamine 
in scopolamine biosynthesis through two C–H bond activations (Scheme 4.2). 
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Scopolamine is widely used for the treatment of motion sickness, Parkinson’s disease, and 
eye inflammation.32-33  
 
Scheme 4.2. C–H bond activations in scopolamine biosynthesis. 
AurH, a cytochrome P450 monooxygenase, links two allylic C atoms with an O 
atom to form an unstrained tetrahydrofuran in aureothin biosynthesis (Scheme 4.3).34-36  
 
Scheme 4.3. C–H bond activation in aureothin biosynthesis. 
 
 Results and discussion 
 
4.2.1. Production of NANL upon feeding synthetic ()-AcAP to yeast with lolO 
expression 
Scientists have long used yeast (Saccharomyces cerevisiae) as a host in studies that 
require in vivo conditions to test the function of an enzyme. Dr. Juan Pan cloned lolO into 
yeast and added ()-AcAP (I synthesized in chapter 2) to the modified organism. Upon 
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GC-MS analysis of an extract, she observed a new peak (compare Figure 4.1b to Figure 
4.1c) whose MS showed m/z = 183 (Figure 4.1a), consistent with NANL. The natural 
conclusion was that LolO alone was sufficient to catalyze both C–H oxidations of AcAP 
and formation of both C–O bonds of the ether bridge, a nearly unprecedented 
transformation. However, it remained possible, though unlikely, that LolO catalyzed only 
one hydroxylation, and that some other, endogenous enzyme in the yeast was catalyzing 
the remaining C–O bond formation to give NANL.37  
 
 
Figure 4.1. (a) Mass spectrum of NANL; (b) GC-MS total ion chromatogram of extract 
from feeding of ()-AcAP to yeast expressing LolO; (c) GC-MS total ion chromatogram 
of extract from feeding of ()-AcAP to yeast with vector-only (plasmid without lolO) 
transformation.37 (Figure created by Dr. Juan Pan.) 
4.2.2. Purified LolO enzyme catalyzes conversion of (±)-AcAP to NANL 
To further support our hypothesis that AcAP was a substrate of LolO and that LolO 
alone catalyzed formation of the ether bridge, Dr. Chang, who was a post-doctoral scholar 
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in Dr. Bollinger lab at Penn State University constructed a plasmid to overexpress an N-
terminally His6-affinity-tagged LolO in E. coli. He then purified the LolO produced by the 
transformed E. coli with nickel column chromatography. He incubated the purified LolO 
with 4 equivalents of synthetic ()-AcAP (I synthesized in chapter 2) in the presence of the 
two cosubstrates, 2-OG and O2, and he analyzed the reaction mixture by LC-MS. He 
observed the consumption of AcAP and production of NANL. This result proved that LolO 
was the only enzyme needed to convert AcAP to NANL (Scheme 4.4).  
 
Scheme 4.4 LolO catalyzes the oxidation of AcAP and 2-OG to NANL. 
Dr. Chang also observed the production of a compound of mass 16 amu more than 
AcAP (Figure 4.2). When the ratio of 2-OG to the natural enantiomer of AcAP was 0.5 
(same as 2-OG:enzyme = 1), he observed the maximum amount of this compound. As he 
increased the ratio of 2-OG to the natural enantiomer of AcAP to 2 (2-OG:enzyme = 4), 
the amount of the novel compound decreased, and the amount of NANL increased, until 
the ratio of AcAP to the novel compound to product NANL was approximately 1:0:1, as 
one would expect if all of the natural enantiomer of AcAP, and none of the unnatural 
enantiomer, had been converted to NANL. On the basis of its MS and its concentration’s 
gradual increase, and then decrease, with increasing amounts of 2-OG, we tentatively 
identified the compound as the presumed intermediate in oxacycle formation, 2- or 7-
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hydroxy-AcAP (Scheme 4.4). To our surprise, when Dr. Chang further increased the ratio 
of 2-OG to the natural enantiomer of AcAP to 4, it appeared that the amount of AcAP 
continued to decrease, and the amount of NANL appeared to continue to increase. Enzymes 
usually prefer the natural enantiomer of their substrate and do not react with the unnatural 
one. However, LolO seemed to be consuming its unnatural substrate in the presence of an 
excess of 2-OG. We hypothesized that LolO might be converting the unnatural enantiomer 
of AcAP not to NANL, but to a species with the same m/z as NANL, perhaps a ketone. 
However, if unnatural enantiomer of AcAP was converting to NANL then LolO is 
promiscuous. 
 
Figure 4.2 LCMS of LolO incubation with various concentrations of ()-AcAP (4:1 with 
respect to enzyme) and cosubstrates 2-OG and O2. 
A B
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 Conclusion 
 
We have shown that LolO alone catalyzes ether bridge formation in AcAP and that NANL 
is the product of the reaction of LolO with AcAP. We have observed a new compound of 
mass 16 amu more than AcAP and that appears to be an intermediate in the oxidation 
reaction, and we have tentatively identified it as either 2- or 7-hydroxy-AcAP (Scheme 
4.4); the evidence obtained thus far does not allow us to determine which is more likely. 
In the next chapter, we will investigate the regiochemistry of this previously unknown 
intermediate in more detail. 
  
 53 
Chapter 5. What is the sequence of C-O bond formation events catalyzed by LolO? 
 
 Introduction 
In the experiment where we subjected (±)-AcAP to purified LolO and varying 
concentrations of 2-OG (Scheme 4.4), we observed a novel compound that reached its 
maximum concentration at low concentrations of 2-OG and nearly disappeared when the 
concentration of 2-OG reached twice that of the natural enantiomer of AcAP (Figure 4.2) 
The MS data showed that the unidentified compound had a mass 16 amu more than (±)-
AcAP and 2 amu more than NANL. These observations suggested that this compound was 
an alcohol intermediate along the pathway from AcAP to NANL. What remained unclear, 
however, was whether this alcohol was installed at the C(2) or C(7) position of AcAP 
(Scheme 4.4). 
The active site of LolO catalysis is not known yet. However, the active sites of 2-
OG-dependent enzymes such as LolO are generally conserved.38 The LolO active site 
consists of a 2-His-1-carboxylate facial triad,29 which is formed by two histidine residues 
and either aspartic acid coordinated to the octahedral mononuclear ferrous ion center 
(Figure 5.1). The other remaining sites around the iron center are available for binding with 
O2, 2-OG and substrate during enzyme catalysis but are typically occupied by water 
molecules.39 The substrate coordinates the enzyme near the active site while O2 and 2-OG 
coordinate directly to the metal center (Scheme 5.1).40-41 Generally, 2-OG-dependent 
enzymes couple the oxidation of their primary substrate with a four-electron reduction of 
O2. Two electrons are provided by the oxidation of the primary substrate, and the remaining 
two electrons are provided by the oxidation of 2-OG (cosubstrate) in order to completely 
reduce O2.
42 
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Figure 5.1. Active site of 2-OG dependent enzyme. 
 
As shown in Scheme 5.1, the commonly accepted mechanism for 2-oxoglutarate-
dependent enzymes starts with binary complex A.39 Coordination of 2-OG with 
displacement of two molecules of H2O gives ternary complex (B). Complex B absorbs at 
530 nm due to a metal-to-ligand charge transfer transition. Coordination of substrate with 
the displacement of another molecule of H2O results in the formation of quaternary 
complex C. One of the O atoms in O2 coordinates directly to the iron(II) center, while the 
uncoordinated O atom attacks the 2-OG carbonyl C atom to give an Fe(IV)=O intermediate 
complex F with the formation of CO2 and succinate. Complex F absorbs at 318 nm due to 
the loss of the metal-to-ligand charge transfer. The highly reactive F begins the oxidation 
of the substrate by abstraction of an H atom from an unactivated C atom of the substrate, 
resulting in the formation of substrate radical and Fe(III)-OH intermediate complex G. The 
hydroxylation of the substrate results from a rebounding of OH from G to the substrate 
radical. The hydroxylated product dissociates, resulting in initial binary complex A, which 
restarts the catalytic cycle. 
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Scheme 5.1. General mechanism for 2-OG-dependent enzymes. 
 
The substitution of an H atom with a D atom on the target C atom of the substrate 
causes the rate of decay of the Fe(IV)=O intermediate complex (Scheme 5.1, complex F) 
to decrease due to a kinetic isotope effect. It follows that if replacement of H with D in a 
substrate causes F to accumulate, then the C atom bearing D must be involved in the C–H 
bond-cleaving step.43 To determine which carbon atom of AcAP is hydroxylated first, we 
could introduce D into the C(2) or C(7) position of AcAP. We could then subject these 
isotopomers to the LolO oxidation reaction in conditions under which only the first C–H 
activation event was expected to occur. If oxidation at C(2) occurred first, we would expect 
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to see accumulation of F in the case of the C(2) isotopomer, but not the C(7) isotopomer. 
By contrast, if oxidation at C(7) occurred first, we would expect to see the opposite.  
The oxidation reaction that LolO catalyzes proceeds on the time scale of a few 
milliseconds. A technique that can measure the kinetics of reactions that take place on the 
time scale of a few milliseconds would help us to determine at which site in AcAP the 
hydroxylation reaction occurs. One of these techniques is stop-flow absorption, which 
monitors the reaction by measuring changes in the UV/Vis region of the electromagnetic 
spectrum.30 As shown in Figure 5.2, in the experimental apparatus used for stop-flow 
absorption, we usually have a reagent and a sample in two different syringes, which a 
syringe drive pushes into the mixing chamber. The syringe drive keeps pushing the reagent 
and the sample continuously through the observation cell into the stopping syringe until 
the stopping block is reached. Thereafter, reaction kinetics are measured 
spectrophotometrically by measuring UV/Vis spectra, circular dichroism, refractive index, 
NMR spectra, etc. The time between the end of mixing and the start of measurement is 
dead time, which is usually a few milliseconds for stop-flow absorption.44 We can use stop-
flow absorption to resolve the two steps of oxidation of AcAP without altering the rate and 
other kinetic measurements.  
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Figure 5.2. Schematic diagram of a stopped-flow analyzer. 
 
 Results and discussion 
 
In order to carry out the stop-flow absorption experiments, I needed to prepare 
AcAP isotopomers that were deuterated separately at C(2) and C(7). Because I did not 
know whether LolO was abstracting the exo or endo H atoms of C(2) and C(7), I decided 
to make substrates that were fully deuterated at these positions. This decision also made 
my synthetic work much simpler, because I did not need to prepare diastereomerically pure 
compounds.  
5.2.1. Synthesis of (±)-7,7-[2H2]-AcAP 
To place two D atoms at the C(7) position of (±)-AcAP, I synthesized 24 (Scheme 
5.2) by literature procedure45, then reduced 24 with NaBD4 to give 25
13. Compound 25 was 
then tosylated, reduced again with NaBD4, and deprotected with 6 M HCl to make the 
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racemic dideuterated proline, ()-3,3-[2H2]-Pro·HCl. This compound was further 
esterified and subjected to a conjugate addition to make diester ()-3,3-[2H2]-8. The diester 
()-3,3-[2H2]-8 was then subjected to Dieckmann condensation, hydrolysis, 
decarboxylation, and NH4OH·HCl addition to give oxime ()-7,7-[
2H2]-10.  
Previously, I had used Raney nickel to reduce 3,3-[2H2]-10 to ()-2´,2´,2´,3-[
2H4]-
AcAP (Scheme 3.2).27 Apart from giving low yields, Raney Ni also caused a large amount 
of H/D exchange, resulting in retention of only one D atom in the ring. The scrambling of 
D with H was even more thorough during the reduction of ()-7,7-[2H2]-10. Consequently, 
I had a great need to find a reducing agent which could give an acceptable yield of AcAP 
without any observable H/D exchange. After an extensive literature search and much 
experimentation with various widely used reducing agents, I found that when Back et al. 
used nickel boride (generated in situ) for the reductive cleavage of deuterated selenides, 
they did not observe any H/D exchange.46 Therefore, I subjected ()-7,7-[2H2]-10 to nickel 
boride (generated in situ) followed by Ac2O. To our delight, I obtained ()-7,7-[
2H2]-
AcAP (97% d2 by HRMS) with no observable loss of D enrichment during the reduction. 
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Scheme 5.2. Synthesis of (±)-7,7-[2H2]-AcAP. 
 
5.2.2. Synthesis of (±)-2,2,8-[2H3]-AcAP 
To place D at the C(2) position, I synthesized diester 8 following the previously 
described procedure (Scheme 2.1).13 I then subjected 8 to Dieckmann condensation, using 
DCl in D2O instead of aqueous HCl for hydrolysis and decarboxylation, and added 
NH2OH·HCl to give ()-2,2,8-[
2H3]-10 (Scheme 5.3). Nickel boride reduction of ()-
2,2,8-[2H3]-10 again proceeded well without any loss in D enrichment, and subsequent 
acetylation gave ()-2,2,8-[2H3]-AcAP (88% d3 by HRMS).  
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Scheme 5.3 Synthesis of (±)-2,2,8-[2H3]-AcAP. 
 
5.2.3. Results of incubation of LolO with deuterated derivatives of (±)-AcAP 
Dr. Juan Pan incubated (±)-AcAP, (±)-7,7-[2H2]-AcAP, and 2,2,8-[
2H3]-AcAP 
with LolO separately under limiting amounts of O2 and 2-OG. She observed that the 
quaternary LolO iron(II) complex absorbed at 520 nm in all three substrates. She also 
observed that, upon the addition of air-saturated buffer, all three substrates caused a 
temporary increase in absorption at 318 nm, but the increase was much larger and lasted 
much longer when (±)-2,2,8-[2H3]-AcAP was the substrate (Figure 5.3). The much larger 
and longer-lasting increase in absorption at 318 nm in the case of (±)-2,2,8-[2H3]-AcAP 
showed that the LolO ferryl complex F (Scheme 5.1) was accumulating to a much greater 
extent due to a decrease in its rate of decay (Kdecay = 1.83 x 10
-3 s-1) resulting from a 
deuterium kinetic isotope effect of kH/kD = 25.96. The data showed that hydroxylation was 
much slower when the C(2) position was deuterated than was the case when the C(7) 
position was deuterated. We concluded that LolO oxidized (±)-AcAP at the C(2) position 
first, resulting in the formation of the intermediate 2-hydroxy-AcAP before the ether bridge 
was completed.   
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Figure 5.3. Stop-flow absorption showing accumulation of C–D cleaving LolO ferryl 
complex F with (±)-2,2,8-[2H3]-AcAP, and not in the cases of (±)-AcAP and (±)-7,7-[
2H2]-
AcAP. (Figure by Dr. Juan Pan.) 
 Characterization of hydroxylated intermediate by NMR 
 
Further support for the hypothesis that hydroxylation of AcAP occurred first at C(2) 
was provided by Dr. Juan Pan. She oxidized AcAP with LolO under conditions of limited 
k
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69.7 ± 0.85
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2-OG, and she used prep HPLC to separate the observed intermediate from unreacted 
AcAP and product NANL, although the sample of intermediate that she obtained contained 
large amounts of NH4OAc and one or two other unidentified compounds. Despite the large 
amounts of impurities, I was able to confirm by 1H NMR that the structure of the 
hydroxylated intermediate was 2-hydroxy-AcAP (Figure 5.4). The NMR spectrum 
featured doublets of doublets at 3.15 ppm (J = 12.6 Hz and 6.6 Hz) and 3.80 ppm (J = 12.7 
Hz and 5.7 Hz). In the 1H NMR spectrum of 2-hydroxy-AcAP, I would expect to see a 
doublet of doublets for the H atoms at C(3), but I would not expect to see such a pattern in 
the 1H NMR spectrum of 7-hydroxy-AcAP. This evidence provided independent support 
for the conclusion from the stop-flow experiment that the observed intermediate was 2-
hydroxy-AcAP, the product of hydroxylation of AcAP at C(2).  
 
Figure 5.4. 500 MHz 1H NMR spectrum of the intermediate, 2-hydroxy-AcAP. 
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Other aspects of the NMR spectra of 2-hydroxy-AcAP were thoroughly consistent 
with the assigned structure. In the 1H–1H COSY spectrum, the doublets of doublets at 3.15 
ppm and 3.80 ppm showed strong correlation with one another and with the most downfield 
resonance, a quartet at 4.41 ppm, which I attributed to the C(2) H atom due to its proximity 
to the electronegative oxygen in the hydroxyl group. The only methylene C atom near to 
C(2) is C(3), allowing us to assign the two doublets of doublets to the C(3) H atoms. The 
other two resonances downfield of 4.0 ppm, those at 4.17 and 4.07 ppm, were likely due to 
the C(1) and C(8) H atoms. The resonance assigned to C(2) showed strong correlation with 
the resonance at 4.17 ppm and not with the resonance at 4.07 ppm, suggesting that the 
former resonance was due to the H atom at C(1) and the latter was due to the H atom at 
C(8). The strong correlation in the COSY spectrum between the resonances arising from 
C(2) and C(1) further supported our assignments.  
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Figure 5.5. 400 MHz 1H–1H COSY NMR spectrum of the intermediate, 2-hydroxy-AcAP. 
 
Figure 5.6. COSY correlations between H atoms at C(1), C(2), C(3), and C(8) in 2-
hydroxy-AcAP. 
There are seven downfield resonances (each integrating to 1H) between 3.5 ppm 
and 4.5 ppm in the 1H NMR spectrum of 2-hydroxy-AcAP. Out of seven, I already assigned 
five as C(1), C(2), C(3) and C(8). I assigned the remaining downfield resonances, at 3.65 
ppm and 3.36 ppm, to the H atoms at C(5) due to their proximity to the electronegative ring 
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N atom. The remaining resonances in the region of 1.9 to 2.4 ppm, which integrate to 4H, 
are likely due to the H atoms at C(6) and C(7). 
Furthermore, when I irradiated the resonance attributed to the H atom attached to 
C2 (quartet at 4.42 ppm), there was strong NOE enhancements of two resonances—one 
attributed to the H atom attached to C8 (quartet at 4.08 ppm) and one attributed to one of 
the two H atoms attached to C3 (dd at 3.90 ppm)—but only a very small NOE enhancement 
of the resonance attributed to the H atom attached to C1 (triplet at 4.18 ppm) (Figure 5.7). 
These data were consistent with 2-endo-hydroxy-AcAP, but not 2-exo-hydroxy-AcAP, as 
I expected because of the endo orientation of the C2–O bond in NANL. 
 
Figure 5.7. 600 MHz NOE difference spectrum of 2-hydroxy-AcAP in D2O upon 
irradiation of the resonance at H2 at 4.42 ppm. 
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 Conclusion 
Our results show that LolO begins C–O bond formation in AcAP by C–H activation 
at C(2), presumably to give a radical intermediate. Hydroxylation then occurs at this 
position to give 2-endo-hydroxy-AcAP. LolO could then catalyze a second C–H activation 
at C(7), and subsequent addition of the C(2) O atom to the presumed radical at C(7) forms 
the ether bridge of NANL (Scheme 5.4). 
 
Scheme 5.4. Oxidation occurs first at C(2) and then at C(7) in AcAP to produce NANL. 
 Experimental Section 
(±)-2,2,8-Trideutero-1-oximinopyrrolizidine ((±)-2,2,8-[2H3]-10) 
 
A solution of n-BuLi in hexane (2.50 M, 11.1 mL) was added to a solution of 
diisopropylamine (4.60 mL) in dry THF (100 mL) at –78 C under nitrogen. After 45 min, 
a solution of 8 (3.40 g, 13.8 mmol) in THF was added dropwise. The reaction mixture was 
stirred at –78 C for 18 h and then brought to RT. D2O (30.0 mL) was added, and then 7.7 
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M DCl in D2O (35.0 mL) was slowly added to the reaction mixture at 0 C. The mixture 
was heated to reflux for 1.5 h. The pH of the reaction mixture was adjusted to 9 by dropwise 
addition of saturated K2CO3 in D2O at 0 C. NH4OH·HCl (0.96 g, 13.8 mmol) was then 
added, and the mixture was heated to reflux for 2 h. The mixture was then stirred for 24 h. 
Solvent and water were evaporated, and the crude mixture was extracted with CH2Cl2. The 
solvent was concentrated and poured onto a silica column and then eluted with 
CH2Cl2:CH3OH:NH4OH (8:2:0.2). The solvent was evaporated to yield (±)-2,2,8-[
2H3]-
10 (0.49 g, 3.47 mmol, 25%) as a light brown powder and as an inseparable mixture of 
diastereomers. 1H NMR (400 MHz, CD3OD):  3.17-2.50 (m, 4H), 2.33-2.18 (m, 1H, 
major), 2.17-2.05 (m, 1H, minor), 1.99-1.50 (m, 3H). 2H NMR (61.5 MHz, CDCl3):  4.07 
(broad s, minor), 3.82 (broad s, major), 2.88-2.21 (merged broad singlets). 13C NMR (100 
MHz, CD3OD):  (major) 26.5, 29.0 (m), 31.1, 51.7, 54.5, 66.2 (t, 21.8 Hz), 166.3;  
(minor) 26.2, 30.5, 51.1, 54.3, 64.2 (t, 21.8 Hz), 166.1. IR (ATR): 3195, 2177, 1844, 1675, 
1509 cm-1. HRMS: m/z calcd for C7H10D3ON2 (M + H): 144.1211; found: 144.1210. 
 
(±)-1-exo-2,2,8-Trideuteroacetamidopyrrolizidine ((±)-2,2,8-[2H3]-AcAP)  
 
Sodium borohydride (0.24 g, 6.25 mmol) was added in portions to a solution of (±)-2,2,8-
[2H3]-10 (96 mg, 0.67 mmol) and NiCl2 (0.26 g, 2.01 mmol) in anhydrous MeOH:THF 
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(3:1, 5.0 mL) at –60 °C over a period of 2 h under nitrogen. (Caution: gas evolution!) After 
complete addition, the resulting black slurry was allowed to warm up to –30 °C and stirred 
at this temperature until no more starting material was detected by TLC (18 h). The reaction 
mixture was warmed to RT, and Ac2O (in excess) was added with vigorous stirring. The 
heterogeneous mixture was stirred for a further 4 h. Concentrated ammonium hydroxide 
(10.0 mL) was added with stirring, and the mixture was filtered through a short pad of 
Celite. The organic solvent was evaporated, and the aqueous layer was extracted with DCM 
(3 times). The combined organic layers were washed with brine (2 times), dried over 
anhydrous MgSO4, and concentrated in vacuum. The crude product was purified by flash 
chromatography in CH2Cl2:CH3OH:NH4OH (6:4:0.2) to afford (±)-2,2,8-[
2H3]-AcAP (28 
mg, 0.16 mmol, 25% yield) as a gummy yellow solid. 1H NMR (400 MHz, CDCl3):  1.60 
(dt, Jt = 7.4 Hz, Jd = 12.3 Hz,  1H), 1.74 (dq, Jd = 12.4 Hz, Jt = 6.9 Hz,  1H), 1.83 (ddt, Jd 
= 18.6 Hz, Jd = 7.4 Hz, Jt = 6.2 Hz,  1H), 1.97 (overlapping s, 4H), 2.61 (dt, Jd = 11.9 Hz, 
Jt = 6.6 Hz, 2H), 3.00 (dt, Jd = 10.5 Hz, Jt = 6.3 Hz, 1H), 3.18 (d, Jd = 10.6 Hz, 1H), 4.10 
(d, Jd = 8.0 Hz, 1H), 5.88 (broad s, 1H). 
2H NMR (61.5 MHz, CDCl3):  3.20 (broad s, 
1H), 2.18 (broad s, 1H), 1.68 (s, 1H). 13C NMR (100 MHz, CDCl3):  23.6, 25.6, 30.7, 
53.3, 55.3, 55.5, 170.1. IR (ATR): 3257, 2239 (weak), 1652, 1552 cm-1. HRMS: m/z calcd 
for C9H14D3ON2 (M + H): 172.2583; found: 172.1524.  
 
1,2-Di-tert-butyl-3-hydroxy-3-deuteropyrrolidine-1,2-dicarboxylate (25) 
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NaBD4 (1.83 g, 43.9 mmol) was added to a solution of 24 (5.01 g, 17.6 mmol) in dry THF 
(66 mL) at 0 ºC in small portions over a period of 1 h. The reaction mixture was stirred for 
3 h at 0 ºC and warmed to RT. The solvent was evaporated, and the residue was dissolved 
in CH2Cl2. The pH of the reaction mixture was adjusted to 2 by the dropwise addition of 
1 N HCl with stirring at 0 ºC. The organic layers were washed with brine, dried with 
MgSO4, and evaporated to give 25 (4.61 g, 15.9 mmol, 91% yield) as a light yellow powder 
and as a mixture of diastereomers. 1H NMR (400 MHz, CDCl3) δ 1.36 (s, 9H; major), 1.38 
(s, 9H; minor), 1.40 (s, 9H; minor), 1.41 (s, 9H; major), 1.88–2.05 (m, 2H), 3.25–3.64 (m, 
2 H), 4.12 (s, 1H; major), 4.17 (s, 1H; minor). 2H NMR (61.5 MHz, CDCl3):  4.44 (broad 
s, 1H). 13C NMR (100 MHz, CDCl3) δ (major) =28.1, 28.3, 31.8, 43.8, 64.1, 71.8 (t, 22.3 
Hz), 80.0, 81.4, 154.1, 169.6; δ (minor) = 28.0, 28.4, 32.4, 44.2, 63.8, 70.9 (t, 22.0 Hz), 
79.7, 81.5, 154.3, 169.7. IR (ATR): 3428, 2165, 1736, 1678 cm-1. HRMS: m/z calcd for 
C14H25DNO5 (M + H): 289.3621: found: 289.1868. 
 
1,2-Di-tert-butyl 3,3-dideuteropyrrolidine-1,2-dicarboxylate (27) 
 
 
 
To the mixture of 25 (13.9 g, 48.5 mmol) and DMAP (5.92 g, 48.5 mmol) in dry CH2Cl2 
(320 mL), triethylamine (49.1 mL, 48.5 mmol) was added. The reaction mixture was 
cooled to 0 ºC, and TsCl (10.7 g, 56.2 mmol) was added in portions over 1 h. Stirring was 
continued for a further 54 h at 0 ºC. A saturated solution of NH4Cl was added to the reaction 
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mixture at 0 ºC, and the aqueous layer was extracted with CH2Cl2. The combined organic 
extracts were washed with brine, dried with MgSO4, and evaporated. Silica gel 
chromatography (30% EtOAc in petroleum ether) afforded tosylate 26 (9.83 g, 22.2 mmol, 
46% yield). The crude 26 was taken to the next step without purification.  
NaBD4 (5,76 g, 13.8 mmol) was added to a solution of crude 26 (10.5 g, 23.8 mmol) 
in dry DMSO (310 mL), and the mixture was heated to 95 ºC under nitrogen for 8 h. The 
reaction mixture was cooled and diluted with brine (effervescence) and extracted with 
ether. The combined organic layers were dried over MgSO4, and the solvent was 
evaporated. Flash chromatography (40% EtOAc in petroleum ether) afforded 27 (4.83g, 
17.7 mmol, 79% yield) as a white gum. 1H NMR (400 MHz, CDCl3) δ 1.44 (s, 9H; major), 
1.45 (s, 9H; minor), 1.47 (s, 9H; major), 1.48 (s, 9H; minor), 1.77–1.97 (m, 2H), 3.47 (m, 
2H), 4.10 (s, 1 H; major), 4.18 (s, 1 H; minor). 2H NMR (61.5 MHz, CDCl3):  1.81 (broad 
s, 1H), 2.07 (broad s, 1H). 13C NMR (100 MHz, CDCl3) δ (major) =23.3, 28.1, 28.4, 30.3 
(p, 20.25 Hz), 46.4, 59.6, 79.6, 80.8. 154.0, 154.4, 172.4; δ (minor) = 24.1, 28.0, 28.5, 29.3 
(p, 20.25 Hz), 46.6, 59.6, 79.4, 153.8, 153.8, 172.3. IR (ATR): 2283-2162, 1737, 1697 cm-
1. GC-MS (EI): 217 (5%), 203 (2%), 187 (3%), 172 (25%), 144(17%), 116 (100%), 72 
(97%), 57 (95%).  
 
(±)-3,3-Dideuteroproline hydrochloride ((±)-3,3-[2H2]-Pro·HCl)  
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Aqueous HCl (6.0 M, 50 mL) was added to a solution of 27 (9.21 g, 33.7 mmol), and the 
reaction mixture was stirred for 2 h at RT. The water was evaporated to give 3,3-[2H2]-
Pro·HCl (2.82 g, 18.4 mmol, 55%) as a brown gum. 1H NMR (400 MHz, D2O) δ 2.04 (t, 
7.3 Hz, 2H), 3.40 (qt, Jt = 7.3 Hz, Jq = 11.8 Hz, 2H), 4.42 (s, 1H). 
2H NMR (61.5 MHz, 
D2O):  2.14 (broad s, 1H), 2.41 (broad s, 1H), 8.39 (broad s, 1H), 8.92 (broad s, 1H). 
13CNMR (100 MHz, D2O) δ 25.7, 30.2 (p, 20.8 Hz), 48.7, 62.0, 174.3. IR (ATR): 3359, 
2032-1926, 1727, 1626 cm-1. EI-MS: Positive ion 117.9 amu, negative ion 173 amu. 
 
(±)-Ethyl 3,3-dideuteroprolinate ((±)-3,3-[2H2]-7) 
 
 
 
The compound 3,3-[2H2]-Pro·HCl (3.15 g, 20.5 mmol) was suspended in ethanol (28 mL) 
and heated to 60 ºC. Thionyl chloride (12.2 g, 102 mmol) was added dropwise to the above 
suspension, and the resulting solution was refluxed for 4 h. Excess thionyl chloride and 
ethanol were evaporated, and the resulting solid was dissolved in CH2Cl2 (18 mL). Water 
(3 mL) was added to the reaction mixture, and concentrated ammonia (5 mL) was added 
to it dropwise. The aqueous layer was extracted with CH2Cl2. The combined organic layers 
were dried over MgSO4, and the solvent was evaporated to afford (2.1 g, 14 mmol, 69%) 
()-3,3-[2H2]-7 as a yellow oil. 
1H NMR (400 MHz, CDCl3) δ 1.28 (t, 7.1 Hz, 3H), 1.65-
1.84 (m, 2 H), 2.92 (dt, Jd = 10.2 Hz, Jt = 6.7 Hz, 1H), 3.08 (dt, Jd = 10.2 Hz, Jt = 6.8 Hz, 
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1H), 3.75 (s, 1H), 4.18 (q, 7.1 Hz, 2H). 2H NMR (61.5 MHz, CDCl3):  1.68 (broad s, 1H), 
1.96 (broad s, 1H). 13C NMR (100 MHz, CDCl3) δ 14.1, 25.1, 29.5 (p, 20.3 Hz), 46.9, 
59.5, 60.1, 175.1. IR (ATR): 3347, 2230-2125, 1727 cm-1. GC-MS (EI): 145 (5%), 72 
(100%), 55 (2%). 
(±)-Ethyl (2S)-N-(3-ethoxy-3-oxopropyl)-3,3-dideuteroprolinate ((±)-3,3-[2H2]-8)  
 
The compound ()-3,3-[2H2]-7 (2.06 g, 14.7 mmol) and ethyl acrylate (7.09 g, 70.8 mmol) 
were added to the reaction vessel and refluxed under nitrogen for 24 h. The reaction mixture 
was allowed to come to RT and concentrated. It was poured onto a silica column, then 
eluted with 40% EtOAc in petroleum ether. The solvent was evaporated to yield ()-3,3-
[2H2]-8 (2.97 g, 12 mmol, 85%) as a yellow oil. 
1H NMR (400 MHz, CDCl3):  1.25 (t, 
7.1 Hz, 3H), 1.28 (t, 7.1 Hz, 3H), 1.75-1.95 (m, 2H), 2.43 (q, 8.5 Hz, 1H), 2.52 (t, 7.6 Hz, 
1H), 2.71-2.81 (m, 1H), 3.04 (dt, Jd = 12.2 Hz, Jt = 7.7 Hz, 1H), 4.15 (td, Jd= 3.4 Hz, Jt = 
8.0 Hz, 1H), 3.21 (s, 1H), 4.13 (q, 7.1 Hz, 2H), 4.18 (q, 7.1 Hz, 2H). 2H NMR (61.5 MHz, 
CDCl3):  1.71 (broad s, 1H), 1.88 (broad s, 1H). 
13C NMR (100 MHz, CDCl3):  13.8, 
13.9, 22.8, 28.5 (p, 20.1 Hz), 33.6, 49.5, 52.9, 60.0, 60.2, 65.3, 171.8, 173.6. IR (ATR): 
2233-2131, 1728, 1612 cm-1. HRMS: m/z calcd for C12H20D2O4N (M + H):  246.3227: 
246.1669. 
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(±)-7,7-Dideutero-1-oximinopyrrolizidine ((±)-7,7-[2H2]-10) 
 
To the solution of diisopropylamine (2.18 mL, 21.5 mmol) in dry THF (85 mL) under 
nitrogen at –78 C, n-BuLi (2.4 M in hexane) (7.5 mL) was added. The reaction mixture 
was allowed to react for 1 h. A solution of ()-3,3-[2H2]-8 (2.21 g, 8.9 mmol) in THF (43 
mL) was prepared and added to the above reaction mixture dropwise. The reaction mixture 
was stirred at –78 C for 18 h and then brought to RT. H2O (30 mL) was added to the 
reaction mixture, and conc. HCl (30 mL) was added to it drop-by-drop at 0 ºC, followed 
by 1.5 h reflux. The reaction mixture was adjusted to pH 9 by adding saturated solution of 
K2CO3 in H2O at 0 C. NH4OH·HCl (0.62 g, 8.9 mmol) was added to the reaction mixture, 
which was allowed to reflux for 2 h. The mixture was then stirred for 24 h. Solvent and 
water were evaporated, and the crude compound was extracted with CH2Cl2. The solvent 
was concentrated, and the remainder was poured onto a silica column and then eluted with 
CH2Cl2:CH3OH:NH4OH (8:2:0.2). Solvent was evaporated to yield ()-7,7-[
2H2]-10 (0.6 
g, 4.2 mmol, 47%) as a light brown powder and as an inseparable mixture of diastereomers. 
1H NMR (400 MHz, CDCl3): δ 4.07 (s, 1H), 3.80 (s, 1H), 3.20 – 2.82 (m, 6H), 2.84 – 2.39 
(m, 6H), 1.94 – 1.68 (m, 4H). 2H NMR (61.5 MHz, CDCl3):  2.29 (broad s, 1H), 2.21 
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(broad s, 1H), 1.88 (s, 1H), 1.75 (broad s, 1H). 13C NMR (100 MHz, CD3OD):  (major) 
26.2,  30.3 (m, 20 Hz), 30.9, 51.7, 54.4, 64.4, 166.2;  (minor) 25.8, 30.2 (m, 20 Hz), 51.1, 
54.2, 62.9, 165.8. IR (ATR): 3202, 2235-2125, 1842, 1675, 1509 cm-1. HRMS: m/z calcd 
for C7H11D2N2O (M + H): 143.1148: 143.1149. 
 
(±)-1-exo-7,7-Dideuteroacetamidopyrrolizidine ((±)-7,7-[2H2]-AcAP) 
 
NaBH4 (0.19 g, 5.0 mmol) was added portionwise to a solution of (±)-7,7-[
2H2]-10 (0.08 
g, 0.5 mmol) and NiCl2 (0.21 g, 1.6 mmol) in anhydrous MeOH:THF (3:1, 5 mL) at –60  
C over a period of 2 h (Caution: gas evolution!). After complete addition, the resulting 
black slurry was allowed to warmed up to –30 °C and stirred at this temperature until no 
more starting material was detected by TLC (18 h). Then, the reaction mixture was warmed 
to room temperature, and Ac2O (in excess) was added with vigorous stirring. The 
heterogeneous mixture was stirred for a further 4 h. Concentrated ammonium hydroxide 
(10 mL) was added with stirring, and the mixture was filtered through a short pad of Celite. 
The organic solvent was evaporated and extracted with DCM (3 times), and the combined 
organic layers were washed with brine (2 times), dried over anhydrous MgSO4, and 
concentrated in vacuo. The crude product was purified by flash chromatography, eluting 
with CH2Cl2:CH3OH:NH4OH (6:4:0.2), to afford (±)-7,7-[
2H2]-AcAP (13.2 mg, 0.078 
mmol, 13%) as a gummy yellow solid. 1H NMR (400 MHz, CDCl3):  1.77 (m, 2H), 1.86 
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(dq, Jd = 12.1 Hz, Jt = 6.0 Hz,  1H), 1.99 (s, 3H), 2.21 (dp, Jd = 13.0 Hz, Jp= 6.6 Hz, 1H), 
2.66 (qd, Jd = 6.7 Hz, Jq = 9.8 Hz, 2H), 3.08 (dt, Jd = 10.7 Hz, Jt = 6.4 Hz, 1H), 3.41-3.22 
(m, 2H), 4.15 (dtd, Jd = 6.7 Hz, Jd= 8 Hz, Jt = 5.1 Hz, 1H), 6.3 (broad s, 1H). 
2H NMR 
(61.5 MHz, CDCl3):  1.98 (broad s, 1H), 1.62 (broad s, 1H). 
13C NMR (100 MHz, 
CDCl3):  23.5, 25.3, 30.0 (m, 20 Hz), 32.8, 53.4, 55.2, 55.37, 70.9, 170.2. IR (ATR): 
3233, 2233 (weak), 1659, 1541 cm-1. HRMS: m/z calcd for C9H15D2ON2 (M + H): 
171.1461; found: 171.2597.  
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Chapter 6. What is the stereochemical course of C-H bond oxidation by LolO? 
 
 Introduction 
We have now shown that LolO abstracts an H atom from C(2) of AcAP first and 
from C(7) second. It remains for us to elucidate the stereochemical course of the C–H bond 
abstractions. We know, of course, that the new C–O bonds at both C(2) and C(7) form on 
the endo face, but the C(2) radical that must precede C–O bond formation can be produced 
by abstraction of either the endo or the exo H atom from C(2), and likewise from C(7) 
(Scheme 6.1). In this chapter, we describe how we determined the stereochemical course 
of H atom abstraction by LolO. 
 
Scheme 6.1. Both exo and endo H atom abstraction in AcAP can allow for an endo bond 
to the O atom. 
 We decided to investigate this question by feeding stereospecifically deuterium-
labeled precursors to loline-producing culture followed by GC–MS analysis of the extent 
of deuterium enrichment of the produced NFL. From our groups’ previous work, we knew 
that C(3) of L-proline became C(7) of NFL (Scheme 6.2).12 With the reasonable 
assumption that the C(3) configuration of L-Pro would remain unchanged until the C–H 
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abstraction event, we expected that feeding cis-3-[2H]-Pro would lead to the intermediate 
7-exo-7-[2H]-AcAP, whereas feeding trans-3-[2H]-Pro would lead to the intermediate 7-
endo-7-[2H]-AcAP. Therefore, if LolO abstracted the endo H atom at C(7) of AcAP, then 
feeding cis-3-[2H]-Pro would give 7-[2H]-NFL, whereas feeding trans-3-[2H]-Pro would 
give NFL with no D atoms incorporated. By contrast, if LolO abstracted the exo H atom at 
C(7) of AcAP, then feeding cis-3-[2H]-Pro would give NFL with no D atoms incorporated, 
whereas feeding trans-3-[2H]-Pro would give 7-[2H]-NFL.  
 
Scheme 6.2. Probing the stereochemistry of H atom abstraction from C(7) of AcAP using 
deuterium-labeled L-proline. 
Similarly, from our groups’ previous work, we knew that C(3) of L-Asp became 
C(2) of NFL (Scheme 6.3).12 If we assumed that the C(3) configuration of L-Asp remained 
unchanged until the C–H abstraction event, we expected that feeding (3R)-3-[2H]-Asp 
would lead to the intermediate 2-exo-2-[2H]-AcAP, whereas feeding (3S)-3-[2H]-Asp 
would lead to the intermediate 2-endo-2-[2H]-AcAP. Therefore, if LolO abstracted the 
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endo H atom at C(2) of AcAP, then feeding (3R)-3-[2H]-Asp would give 2-[2H]-NFL, 
whereas feeding (3S)-3-[2H]-Asp would give NFL with no D atoms incorporated. By 
contrast, if LolO abstracted the exo H atom at C(2) of AcAP, then feeding (3R)-3-[2H]-
Asp would give NFL with no D atoms incorporated, whereas feeding (3S)-3-[2H]-Asp 
would give 2-[2H]-NFL.  
 
Scheme 6.3. Probing the stereochemistry of H atom abstraction from C(2) of AcAP using 
deuterium-labeled L-Asp. 
We hypothesize that LolO abstracts the endo H atom from both C(2) and C(7). The 
Fe center in LolO almost certainly delivers the OH group to the endo face of C(2), so it is 
likely that AcAP coordinates to the Fe center on its endo face. It then seems likely that the 
abstraction of H atoms from both the C(2) and C(7) positions of AcAP occurs from the 
endo face due to the proximity of the Fe center to the endo face of AcAP. 
 Results and discussion 
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6.2.1. Synthesis of cis- and trans-3-[2H]-Pro 
In order to study the stereochemistry of H atom abstraction at C(7) of AcAP,  I 
prepared regio- and stereospecifically deuterated prolines from trans-3-hydroxy-L-Pro 
(28). Following the literature procedure,13 the N of proline derivative 28 was protected 
with a Boc group, and the product was converted to its t-butyl ester (Scheme 6.4). The 
product 29 was then divided into two portions. One portion was tosylated, reduced with 
NaBD4, and deprotected with 6 M HCl to give cis-3-[
2H]-Pro·HCl. The other portion of 
29 was subjected to a Mitsunobu reaction to give 31, which was then tosylated, reduced 
with NaBD4, and deprotected with 6 M HCl to give trans-3-[
2H]-Pro·HCl. 
 
Scheme 6.4. Synthetic routes to cis- and trans-3-[2H]-Pro·HCl. 
 
6.2.2. Results of feeding experiments with cis- and trans-3-[2H]-Pro 
 
Dr. Juan Pan fed cis-3-[2H]-Pro·HCl and trans-3-[2H]-Pro·HCl to cultures of E. 
uncinata at 4 mM final concentrations. I extracted the cultures with CHCl3, and the 
products were analyzed by GC–MS (Figure 6.1). The MS of undeuterated NFL has a 
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prominent peak at 183 amu that is assigned as an [M + H] peak, plus a small peak at 184 
amu due to a heavier isotope of C, N, or O. Incorporation of one D atom into NFL results 
in an increase in the intensity of the peak at 184 amu (+1 amu). I found that NFL isolated 
from the culture which was fed with cis-3-[2H]-Pro·HCl retained one D atom in NFL, as 
shown by the large increase in the intensity of the 184 amu peak (Figure 6.1A), whereas 
the culture fed with trans-3-[2H]-Pro·HCl showed only a small increase in the intensity of 
the 184 amu peak (Figure 6.1B). 
 
 
Figure 6.1. Mass spectrum showing NFL production in loline-producing culture from the 
feeding of, (A) cis-3-[2H]-Pro·HCl; (B) trans-3-[2H]-Pro·HCl; (C) without any feeding. 
I calculated the extent of incorporation of D in the two cases to be 30.5% and 2.9%, 
respectively (Table 6.1). In both cases, the incorporation of D was significantly different 
from control (Figure 6.1C; p = 0.04 and 0.03, respectively). I attribute the much smaller 
2.9% incorporation from the feeding of trans-3-[2H]-Pro·HCl to contamination of this 
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isomer with some cis-3-[2H]-Pro·HCl, as evident in the 1H NMR spectrum of trans-3-
[2H]-Pro·HCl (Figure 6.2).  
Table 6.1. Relative deuterium incorporation from deuterated prolines in NFL. (a) 
Significantly different from control (p = 0.03); (b) significantly different from controls (p 
= 0.04). 
Compounds Conc. 
(mM) 
Amu shift 
(183 + 1) 
% enrichment of 183 + 1 amu 
peak (mean ± SD) 
cis-3-[2H]-Pro·HCl  4 +1 30.51 ± 2.26(a) 
trans-3-[2H]-Pro·HCl  4 +1 2.93 ± 0.27(b) 
 
H	atom	trans	to	
carboxylate	group	at	C(3)
H	atom	cis	to	carboxylate	
group	at	C(3)	is	missing
H	atom	trans	to	carboxylate	
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H	atom	cis	to	carboxylate	
group	at	C(3)
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Figure 6.2. 1H NMR spectra showing contamination of trans-3-[2H]-Pro·HCl with cis-3-
[2H]-Pro·HCl. (A) Pro; (B) cis-3-[2H]-Pro·HCl; (C) trans-3-[2H]-Pro·HCl with small 
amount of cis-3-[2H]-Pro·HCl as contaminant. 
The strong incorporation of one D atom into the isolated NFL when fungal cultures 
were fed with cis-3-[2H]-Pro·HCl suggested that LolO abstracted the endo hydrogen at the 
C(7) position of AcAP during ether bridge formation, a conclusion that was consistent with 
our original hypothesis (Scheme 6.5). 
 
 
Scheme 6.5. Abstraction of endo H atom by LolO from C(7) of AcAP. 
 
6.2.3. Synthesis of (3R)-(3-2H)-Asp and (3S)-(2,3-2H2)-Asp 
To ascertain whether LolO abstracted the endo or exo H atom at C(2) of AcAP, I 
prepared stereospecifically deuterium-labeled aspartic acids chemoenzymatically. I first 
cloned, expressed, and purified the aspartate aminotransferase B (AspB) enzyme by 
standard molecular biology tools.47 (an AspB-expression plasmid was kindly contributed 
by Dr. M. Otzen from University of Groningen, Nijenborgh, Netherlands.) Following the 
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literature procedure,48 I then added commercially available 2,3-[2H2]-fumaric acid to a 
solution of AspB in aqueous NH4Cl, obtaining (3S)-2,3-[
2H2]-Asp with 88.9% 
dideuteration as measured by HRMS. Similarly, I added undeuterated fumaric acid to a 
solution of AspB and ND4Cl in D2O, obtaining (3R)-3-[
2H]-Asp with 94.5% 
monodeuteration by HRMS (Scheme 6.6). (In this latter case, I used AspB that I had 
purified in D2O buffer, because AspB purified in H2O buffer gave a much lower 
incorporation of D into the final product.)  
 
Scheme 6.6. Synthetic route to (3R)-3-[2H]-and (3S)-2,3-[2H2]-Asp. 
 
6.2.4. Possible complications due to deuterium at the C(2) position of (3S)-2,3-[2H2]-
Asp  
 
Due to the nature of our synthetic route to the (3S)-deuterated isotopomer of Asp, I 
could not avoid introducing deuterium into its C(2) position. Unfortunately, the 
incorporation of deuterium into the C(2) position led to complications in our ability to draw 
conclusions from certain experimental outcomes. Specifically, multiple PLP enzymes in 
the biosynthetic pathway might or might not exchange the C(2) D atom of (2S,3S)-2,3-
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[2H2]-Asp for an H atom (Scheme 6.7). If D–H exchange did not occur, then depending on 
whether the endo or exo H at C(2) of AcAP was abstracted, I would obtain either [2H]-
NFL or [2H2]-NFL. On the other hand, if D–H exchange did occur, I would obtain either 
undeuterated NFL or [2H]-NFL. Hence, if I obtained [2H]-NFL, then, without prior 
knowledge of whether the C(2) D atom of (2S,3S)-2,3-[2H2]-Asp was involved in 
exchange, it would have been difficult for us to determine whether LolO abstracted the 
endo or exo H atom at C(2) of AcAP. We would revisit this after feeding experiments.  
 
Scheme 6.7. Complications due to deuterium at C(2) position of (3S)-2,3-[2H2]-Asp. 
6.2.5. Results of feeding experiments with (2S,3S)-3-[2H]-Asp and (2S,3S)-2,3-[2H2]-
Asp. 
 
I fed (3R)-3-[2H]- and (3S)-2,3-[2H2]-Asp to loline-producing cultures separately 
in triplicate. Table 6.2 shows the results of GC-MS analysis of the NFL obtained from the 
feedings. The feedings of (3R)-3-[2H]-Asp gave NFL that was significantly more enriched 
in one D atom than unfed control. By contrast, the feeding of (3S)-2,3-[2H2]-Asp gave NFL 
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that was not significantly different from unfed control. The feeding of (3S)-2,3-[2H2]-Asp 
gave essentially no [2H2]-NFL. These results led us to conclude that, (1) the C(2) D atom 
was largely exchanged for H during the pathway leading up to AcAP, and (2) in support of 
our original hypothesis, the endo H atom at the C(2) position of AcAP was abstracted by 
LolO during ether bridge formation in the loline biosynthetic pathway (Scheme 6.10).  
Table 6.2. Relative deuterium incorporation from deuterated aspartic acids in NFL (a) 
Significantly different from control; (b) Not significantly different from control.  
Compounds Conc. 
(mM) 
Amu shift 
(M + n) 
% enrichment of  
183 + Z amu 
peak 
(mean ± SD) 
p value with  
respect to  
control 
(3R)-3-[2H]-Asp 4 +1 4.1 ± 0.9 0.0029(a) 
(3S)-2,3-[2H2]-Asp 4 +1 1.1 ± 0.4 0.9137(b) 
(3S)-2,3-[2H2]-Asp 4 +2 0.2 ± 0.3 0.8139(b) 
 
Earlier, I noted that our interpretation of the deuterated aspartic acids feeding results 
depended on the reasonable assumption that the C(2) configuration of Asp was not altered 
in the course of loline biosynthesis. Further reflection on the biosynthetic pathway, 
however, has revealed to us that this assumption is incorrect. I know that Pro and Hse 
(probably O-Ac-Hse) are the precursors to loline biosynthesis. We have previously shown 
that Pro and O-Ac-Hse combine through a -substitution reaction to give the diamino diacid 
N-(3-amino-3-carboxypropyl)proline (NACPP) (Scheme 1.5), and circumstantial evidence 
suggests that LolC, a PLP enzyme, catalyzes this step.15 The mechanism of PLP-catalyzed 
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-substitution reactions is as follows (Scheme 6.8): temporary conversion of the -amino 
acid of O-Ac-Hse to an -imino acid, tautomerization to an enamine, and elimination of –
OAc to form an ,-unsaturated iminium ion. A nucleophile then reacts with the ,-
unsaturated iminium ion to produce a new enamine, which is then restored to the initial -
amino acid. During the formation of first enamine, LolC removes H+ from C(3) of Hse, 
the very same position that I was deuterating in Asp in order to probe which H atom (exo 
or endo) LolO abstracted from C(2) of AcAP.  
 
Scheme 6.8. Proposed mechanism by which LolC and O-acetylhomoserine (thiol) lyase 
catalyze -substitution reactions. 
If LolC is catalyzing the combination of Pro and O-Ac-Hse through the above 
mechanism, then the stereochemistry and the extent of D labelling installed at C(3) of (3R)- 
and (3S)-3-[2H]-Asp is prone to change in numerous ways (Scheme 6.9). LolC showed 
similarity to the -type PLP enzyme cystathionine -synthase.15 The mechanism proposed 
for the cystathionine -synthase on the basis of crystal structure have same amino acid 
removes and restores the C(3) H+.49 If LolC has similar active site as cystathionine -
synthase, then we can assume that LolC will restore H+ or D+ to the same face of C(3) 
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from which LolC removes it. Another complication though, is that the enzyme might 
restore the same atom that it removed, or it might restore a different one. If the enzyme 
removes the pro-R H+ or D+ and replaces it with a different H+ (Scheme 6.9A), it would 
convert the R isotopolog to undeuterated, and it would preserve the configuration of the S 
isotopolog. Similarly, if the enzyme removes the pro-S H+ or D+ and replaces it with a 
different H+ (Scheme 6.9B), it would preserve the configuration of the R isotopolog, and 
it would convert the S isotopolog to undeuterated.  
 

Scheme 6.9. Effect of LolC on D atom content and configuration of Asps deuterated at 
C(3). (A) LolC removes pro-R H/D, restores a different H+ to same face.; (B): LolC 
removes pro-S H/D, restores a different H+ to same face. 
With this analysis, we could predict the effect of six different scenarios on the 
extent of deuteration of the NFL that we would obtain upon feeding our two Asp 
isotopologs (Table 6.3). After matching the predicted results to the actual results from the 
feeding experiments (Table 6.2), we hold to our original conclusion that LolO abstracts the 
endo H atom from C(2) (Scheme 6.10).  
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Table 6.3 Possible outcomes of feeding experiments of (3R)- and (3S)-3-[2H]-Asp after 
LolC and LolO reactions. The first and third cells match the observed feeding results. (d1 
denotes monodeuterated and d0 denotes undeuterated) 
3-[2H]-Asp 
configuration 
at C3 
H or D that 
LolC removes 
from C3 
LolC 
restores on 
C3 
Asp C3 
after 
LolC 
NFL from 
endo H 
abstraction 
NFL from 
exo H 
abstraction 
R pro-R or pro-S same atom  R d
1
 d
0
 
S pro-R or pro-S same atom  S d
0
 d
1
 
R pro-R different H+  none d
0
 d
0
 
S pro-R different H+  S d
0
 d
1
 
R pro-S different H+ R d
1
 d
0
 
S pro-S different H+  none d
0
 d
0
 
 
 
 
 
Scheme 6.10. Abstraction of endo hydrogen atom by LolO from C(2) of AcAP. 
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 Conclusion 
Our experiments support the hypotheses that LolO abstracts the endo H atoms from 
the C(2) and C(7) positions of AcAP. This information is consistent with a mechanism 
where AcAP binds to LolO in such a way that the catalytic Fe center resides on the endo 
face of AcAP, and the Fe center is intimately involved in both the C–H abstractions and 
the C–O bond formations leading to NANL. 
 
 Experimental Section 
 
6.4.1. Synthesis of cis- and trans-3-[2H]-L-prolines 
 
(2S,3S)-N-tert-Butoxycarbonyl-trans-3-hydroxyproline (29) 
 
A 10% aqueous solution of NaOH (2.2 mL) was added to alcohol 28 (1.0 g, 7.6 mmol) 
suspended in a mixture of THF/H2O (2:1, 10 mL). Di-tert-butyl dicarbonate (1.7 g, 7.6 
mmol) was added, and the reaction mixture was stirred for 21 h at RT. The organic solvent 
was evaporated, and the mixture pH was adjusted to 2 by addition of 10% aqueous KHSO4 
solution. The mixture was extracted with EtOAc, washed with brine, dried with MgSO4, 
and evaporated to give crude 29 (1.7 g, 7.5 mmol, 98% yield) as a yellow viscous oil. 1H 
NMR (400 MHz, CDCl3) δ 1.43 (s, 9H; major), 1.47 (s, 9H; minor), 1.82–1.93 (m, 2H; 
minor), 1.98–2.10 (m, 2H; major), 3.46–3.62 (m, 4H), 4.10 (br, 1H; major), 4.17 (br, 1H; 
minor), 4.37-4.41 (m, 1H). 13C NMR (100 MHz, CDCl3) δ (major) 28.7, 33.0, 45.5, 69.6, 
76.0, 81.6, 156.2, 174.5; δ (minor) 28.9, 33.6, 45.9, 69.3, 75.2, 81.5, 156.6, 174.2. IR 
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(ATR): 3283, 1741, 1653 cm-1.  
 
tert-Butyl (2S,3S)-N-tert-butoxycarbonyl-trans-3-hydroxy-L-proline (29) 
 
 
 
Neat 34 (5.8 mL) was added to 33 (1.54 g, 6.67 mmol), and the mixture was stirred for 12 
h at 80 ºC under nitrogen. The solution was cooled to RT, and H2O (5.8 mL) was added. 
The mixture was stirred for 22 h at RT. Saturated aqueous NaHCO3 (15 mL) was added, 
and the mixture was extracted with Et2O. The organic layer was washed with water and 
brine and dried with MgSO4. The crude compound was purified by flash chromatography 
(5% MeOH in CH2Cl2) to give 29 (1.02 g, 3.55 mmol, 53% yield) as a yellow viscous oil. 
1H NMR (400 MHz, CDCl3) δ 1.35 (s, 9H; major), 1.37 (s, 9H; minor), 1.38 (s, 9H; minor), 
1.39 (s, 9H; major), 1.78–2.04 (m, 2H), 2.8 (br s, 1H; minor), 2.9 (br s, 1H; major), 3.44–
3.60 (m, 2 H), 4.02 (br s, 1H; major), 4.08 (br s, 1H; minor), 4.26–4.35 (m, 1H). 13C NMR 
(100 MHz, CDCl3) δ (major) 27.8, 31.8, 44.2, 68.7, 74.7, 79.7, 81.2, 154.2, 170.3; δ 
(minor) 28.2, 32.4, 44.5, 68.6, 73.7, 79.5, 81.4, 154.5, 170.2; IR (ATR): 3454, 3357, 1735, 
1660 cm-1. HRMS: m/z calcd for C14H26NO5 (M + H): 288.3635: 288.1807. 
 
tert-Butyl (2S,3R)-N- tert-Butoxycarbonyl-cis-3-deuteroprolinate (30) 
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Triethylamine (1.45 mL, 10.4 mmol) was added to a mixture of alcohol 29 (0.3 g, 1 mmol) 
and DMAP (0.13 g, 1.0 mmol) in dry CH2Cl2 (20 mL). TsCl (0.23 g, 1.2 mmol) was added 
in portions over 1 h at 0 ºC, and the reaction mixture was stirred at 0 ºC for 54 h. A saturated 
solution of NH4Cl was then added at 0 ºC, and the aqueous layer was extracted with 
CH2Cl2. The combined organic extracts were washed with brine, dried with MgSO4, and 
evaporated. Silica gel chromatography (50% EtOAc in petroleum ether) afforded the 
tosylate (0.36 g, 78% yield). The tosylate (0.36 g, 0.82 mmol) was dissolved in dry DMSO 
(12 mL), and NaBD4 (0.21 g, 4.9 mmol) was added. The reaction mixture was heated to 
95 ºC under nitrogen for 8 h. It was cooled and diluted with brine (effervescence), and the 
aqueous phase was extracted with Et2O. The combined organic layers were dried over 
MgSO4, and the solvent was evaporated. Flash chromatography (40% EtOAc in petroleum 
ether) afforded 30 (0.185 g, 0.68 mmol, 83% yield) as a white gum. 1H NMR (400 MHz, 
CDCl3) δ 1.38 (s, 9H), 1.40 (s, 9H), 1.68–1.94 (m, 2H), 2.01–2.18 (m, 1H), 3.12-3.55 (m, 
2H), 4.04 (d, 8.6 Hz, 1H; major), 4.12 (d, 8.6 Hz, 1H; minor). 13C NMR (100 MHz, CDCl3) 
δ (major) 23.4, 28.1, 28.5, 30.7 (t, 20.81 Hz), 46.4, 59.8, 79.7, 80.9, 154.1, 172.4; δ (minor) 
23.2, 28.1, 28.5, 46.6, 59.7, 79.5, 154.4, 172.3. 2H NMR (61.5 MHz, CDCl3):  1.89 (broad 
s, 1H). IR (neat): 1739, 1701 cm–1. HRMS [M]+: m/z calcd for C17H21D2NO4: 307.1747: 
307.1744. 
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cis-3-Deuteroproline·hydrochloride (cis-3-[2H]-Pro·HCl) 
 
 
 
Compound 30 (185 mg, 0.680 mmol) was dissolved in 6 M HCl (7 mL), and the reaction 
mixture was stirred for 2 h at RT. The water was evaporated to give cis-3-[2H]-Pro·HCl 
(79 mg, 0.52 mmol, 87%) as a brown gum. 1H NMR (400 MHz, D2O) δ 2.01–2.12 (q, 7.1 
Hz, 2H), 2.35-2.49 (m, 1H), 3.42 (qt, Jt = 7.3 Hz, Jq = 11.7 Hz, 2H), 4.43 (d, 8.8 Hz, 1H). 
13C NMR (100 MHz, D2O) δ 25.8, 30.5 (t, 20.4 Hz), 48.8, 62.1, 174.4. 
2H NMR (61.5 
MHz, D2O):  2.14 (broad s, 1H), 8.38 (broad s, 1H), 8.91 (broad s, 1H). IR (ATR): 3398, 
2464, 1915, 1725 cm-1. EI-MS: Positive ion 116.9 amu ([M + H]), negative ion 35.1 amu 
([Cl]). 
 
tert-Butyl (2S,3R)-N-tert-butoxycarbonyl-cis-3-hydroxyproline (31) 
 
 
 
DEAD (848 mg, 4.87 mmol) in dry THF (8 mL) was added to a solution of 
triphenylphosphine (1.28 g, 4.87 mmol), benzoic acid (0.59 g, 4.9 mmol), and 29 (700 mg, 
2.44 mmol) in dry THF (20 mL) at 0 ºC under nitrogen. The reaction mixture was stirred 
for 5 min at 0 ºC, and then for 22 h at RT. The solvent was evaporated, the residue was 
suspended in methanolic KOH solution (1.0 M, 43 mL) at 0 ºC, and the mixture was stirred 
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for 30 min. The solvent was evaporated, and the residue was partitioned between EtOAc 
and water. The organic layer was washed with brine, dried with MgSO4, and evaporated. 
Flash chromatography (30% acetone in petroleum ether) afforded 31 (624 mg, 2.17 mmol, 
89% over two steps) as a white solid. 1H NMR (400 MHz, CDCl3) δ 1.35 (s, 9H; major), 
1.37 (s, 9H; minor), 1.39 (s, 9H; minor), 1.40 (s, 9H; major), 1.86–2.06 (m, 2H), 3.23–3.41 
(m, 1H), 3.44–3.61 (m, 1H), 4.12 (d, 7.0 Hz, 1H; major), 4.15 (d, 7.0 Hz, 1H; minor), 4.30–
4.40 (p, 6.6 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ (major) 28.0, 28.1, 31.7, 43.6, 64.0, 
71.9, 79.7, 81.1, 154.0, 169.5; δ (minor) 27.9, 28.2, 32.2, 44.0, 63.8, 71.0, 79.5, 81.2, 154.2, 
169.6. IR (ATR): 3240, 2162, 1740, 1693 cm-1. HRMS: m/z calcd for C14H26NO5 (M + 
H): 288.3635: 288.1807. 
 
tert-Butyl (2S,3S)-N-tert-butoxycarbonyl-trans-3-deuteroprolinate (32) 
  
 
 
Triethylamine (3.0 mL, 22 mmol) was added to a mixture of alcohol 31 (624 mg, 2.17 
mmol) and DMAP (0.265 g, 2.17 mmol) in dry CH2Cl2 (40 mL). TsCl (0.50 g, 2.6 mmol) 
was added in portions over 1 h at 0 ºC, and the reaction mixture was stirred at 0 ºC for 54 
h. A saturated solution of NH4Cl was added at 0 ºC, and the aqueous layer was extracted 
with CH2Cl2. The combined organic extracts were washed with brine, dried with MgSO4, 
and evaporated. Silica gel chromatography (50% EtOAc in petroleum ether) afforded the 
tosylate (959 mg, 2.17 mmol, 57% yield). The tosylate (549 mg, 1.24 mmol) was dissolved 
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in dry DMSO (20 mL), and NaBD4 (260 mg, 6.22 mmol) was added to it. The reaction 
mixture was heated to 95 ºC under nitrogen for 8 h. It was cooled and diluted with brine 
(effervescence), and the aqueous phase was extracted with Et2O. The combined organic 
layers were dried over MgSO4, and the solvent was evaporated. Flash chromatography 
(40% EtOAc in petroleum ether) afforded 32 (256 mg, 0.941 mmol 75%) as a white gum. 
1H NMR (400 MHz, CDCl3) δ 1.36 (s, 9H), 1.39 (s, 9H), 1.68–1.92 (m, 3H), 2.01–2.18 
(m, 1H), 3.19-3.55 (m, 2H), 4.03 (s, 1H; major), 4.11 (s, 1H; minor). 13C NMR (100 MHz, 
CDCl3) δ (major) 23.4, 28.1, 28.5, 30.7 (t, 20.3 Hz), 46.4, 59.7, 79.7, 80.9, 154.1, 172.4; δ 
(minor) 24.2, 28.1, 28.5, 29.7 (t, 20.7 Hz), 46.6, 59.7, 79.5, 154.4, 172.4. 2H NMR (61.5 
MHz, CDCl3):  2.14 (broad s, 1H); IR (neat): 1738, 1689 cm
-1. HRMS [M]+: m/z calcd 
for C17H21D2NO4: 307.1747: 307.1744. 
 
trans-3-Deuteroproline hydrochloride (trans-3-[2H]-Pro·HCl) 
 
 
 
Compound 32 (256 mg, 0.340 mmol) was dissolved in 6 M HCl (7.5 mL), and the reaction 
mixture was stirred for 2 h at RT. The water was evaporated to give trans-3-[2H]-Pro·HCl 
(107 mg, 0.704 mol, 98%) as a brown gum. 1H NMR (400 MHz, D2O) δ 2.00–2.25 (m, 
3H), 3.36–3.53 (m, 2 H), 4.44 (d, 7.0 Hz, 1H). 13C NMR (100 MHz, D2O) δ 25.8, 30.6 (t, 
22 Hz), 48.7, 62.1, 174.5. 2H NMR (61.5 MHz, D2O):  2.39 (broad s, 1H), 8.35 (broad s, 
1H), 8.88 (broad s, 1H). IR (ATR): 3355, 2165-2066, 1736 cm-1. EI-MS: Positive ion 116.9 
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amu ([M + H]), negative ion 35.1 amu ([Cl]).  
 
6.4.2. Transformation, expression and purification of AspB-His6 enzyme 
The procedure for transformation, expression and purification of AspB-His6 was 
performed as reported by B. Feringa, D. B. Janssen, G. J. Poelarends et al. with 
modification.47 
6.4.2.1. Transformation and expression  
The AspB-His6 plasmid (with pBAD expression system) was transformed into Top10 cells, 
plated on a LB plate with ampicillin antibiotics, and incubated overnight at 37 ºC. A colony 
of Top10 cells containing AspB-His6 plasmid was collected using a pipette tip and used to 
inoculate 5 mL LB medium (with ampicillin) in a 14 mL Falcon tube with loose cap. (We 
used 100 μL of ampicillin (100 mg/ml) for 100 mL LB.) The mixture was incubated in a 
shaker overnight at 37 ºC at 180 rpm. The tube was removed from incubator and poured 
into 500 mL LB with ampicillin and incubated at 37 ºC, 180 rpm. Optical density at 600 
nm with UV/Vis was measured until it reached 0.7-0.8. Thereafter, the culture was induced 
with sterile arabinose solution (final concentration 0.08%) and incubated in a shaker 
overnight at 37 ºC at 180 rpm. The cells were centrifuged at 4000 rpm and 4 °C for 15 min 
using a JA-25-50 rotor. The LB was decanted, and the cell pellet was transferred into a 50 
mL Falcon tube and suspended in lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM 
imidazole, pH 8.0) in an ice bath. The cells were disrupted by sonicating in Branson 250 
microtip for 3  1 min with 3 min rest in between each cycle (60 W output). The lysate was 
centrifuged for 30 min at 17,000 g at 4 °C using JA-25-50 rotor to remove cell debris. The 
protein was in the supernatant, which was collected into a 15 mL tube.  
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6.4.2.2. Purification with Ni NTA agarose  
All the steps in the AspB-His6 purification were done at 4 °C. The Ni NTA agarose solution 
(4 fractions of 1 mL) was equilibrated 3 times with lysis buffer. The 1 mL lysate solution 
was added to each fraction and incubated at 4 °C for 30 min under rotation in an end-over-
end rotor. The column was washed three times with buffer A (50 mM NaH2PO4, 300 mM 
NaCl, 20 mM imidazole, pH 8.0; 0.5 mL/column). The AspB-His6 protein was eluted from 
the column by using buffer B (50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH 
8.0; 0.25 mL/column). The purified protein was passed through PD-10 column using 50 
mM equilibrating phosphate buffer (pH 8). The fractions were concentrated in a centrifugal 
concentrator with 30 kDa molecular weight cut-off (Pall Corporation, Port Washington, 
NY), and the absorbance of the protein was measured at 280 nm. The protein was diluted 
with sterile 10% glycerol and stored at –80 ºC until further use. 
 
6.4.3. Synthesis of deuterium-labeled aspartic acids 
 
(2S,3S)-2,3-Dideutero-L-aspartic acid ((2S,3S)-2,3-[2H2]-Asp) 
 
 
2,3-Dideuterofumaric acid (0.50 g, 4.2 mmol) was suspended in water (4 mL), the pH was 
adjusted to 9 with aqueous NH4OH, and MgCl2·6H2O (0.516 mg, 2.54 mmol) and KCl 
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(44 mg, 1.1 mmol) were added. The pH was again adjusted to 9 with aqueous ammonia 
hydroxide, and AspB enzyme was added. The reaction mixture was incubated at 25 °C for 
72 h. The solution was heated at 100 ºC for 2 min and then filtered through Celite. The 
filtrate pH was reduced to 1 with 12 M HCl and extracted with Et2O (2 times). The aqueous 
layer was adjusted to pH 4, and EtOH was added to precipitate the aspartic acid. Filtration 
gave (2S,3S)-2,3-[2H2]-Asp as a white solid (0.41 g, 3.0 mmol, 68%). 
1H NMR (400 MHz, 
D2O) δ 3.10 (s, 1H). 
2H NMR (61.5 MHz, D2O):  2.14 (broad s, 1H), 2.41 (broad s, 1H). 
13C NMR (100 MHz, D2O) δ 34.5 (t, 20 Hz), 50.7 (t, 21.4 Hz), 173.0, 174.6. IR (ATR): 
2165-2076, 1685, 1639 cm-1. HRMS: m/z calcd for C4H6D2NO4 (M + H): 136.1227: 
136.0575. 
 
(3R)-3-deutero-L-aspartic acid ((3R)-3-[2H]-Asp) 
 
 
Fumaric acid (0.5.0 g, 4.3 mmol) was suspended in D2O (20 mL), the pH was adjusted to 
9 with ND4OH in D2O, and MgCl2.6H2O (525 mg, 2.58 mmol) and KCl (44.7 mg, 1.15 
mmol) were added. The pH was again adjusted to 9 with ND4OH in D2O, and AspB 
enzyme (purified in D2O buffer) was added. The reaction mixture was incubated at 25 °C 
for 72 h. The solution was heated to 100 ºC for 2 min and then filtered through Celite. The 
filtrate pH was reduced to 1 with 12 M HCl and extracted with Et2O (2 times). The aqueous 
layer was adjusted to pH 4, and EtOH was added to precipitate the aspartic acid. Filtration 
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gave (3R)-3-[2H]-Asp as white solid (213 mg, 1.59 mmol, 48%). 1H NMR (400 MHz, 
D2O) δ 2.94 (d, 7.5 Hz, 1H), 4.06 (d, 7.58 Hz, 1H). 
2H NMR (61.5 MHz, D2O):  2.86 
(broad s, 1H). 13C NMR (100 MHz, D2O) δ 34.5 (t, 20.2 Hz), 50.8, 173.0, 174.6. IR (ATR):  
2231-2078, 1684, 1639 cm-1. HRMS: m/z calcd for C4H7DNO4 (M + H): 135.1166: 
135.0512. 
 
6.4.4. Fungal isolation from infected plant (e167) 
The procedure for fungal (Neotyphodium uncinatum) isolation was same as reported in our 
groups’ previous work.11 Leaf blades from the grasses (number 167 from the plant 
collection) were collected from the greenhouse. They were cleaned and washed three times 
with autoclaved water in a 50 mL Falcon tube to remove any soil. They were sterilized by 
washing with 95% ethanol for 10 sec, followed by rinsing with autoclaved water. They 
were soaked in 50% bleach for 30 min, with shaking every 10 min. The bleach was slowly 
poured into the waste container, and each tube was washed three times with autoclaved 
water. The leaf blades were cut into 2-mm sections and plated on PDA plates with penicillin 
(350 uL) and streptomycin (350 uL) using sterilized forceps. They were incubated at 22 ºC 
for two weeks with frequent checking for unknown growth. After 2 weeks, fungal 
mycelium was removed with a sterile blade, homogenized in sterile water with a sterile 
stick, and drop-inoculated on an antibiotic-free PDA plate. In order to have fresh fungus, 
it was subcultured every 7-10 days. 
 
6.4.5. Preparation of minimal media for the culture of fungus 
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Minimal media was prepared as reported in our groups’ previous work.11 A basal salt 
solution of pH 5.5 was made by mixing K2HPO4 (1.369 g) and KH2PO4 (4.083 g) in 100 
mL of Milli-Q water. MOPS (5.856 g) was then added, the pH was adjusted to 5.5 with 
NaOH, and the solution was autoclaved. MgSO4 (2mM, 0.493 g) was dissolved in 100 mL 
of Milli-Q water and autoclaved separately to prevent precipitation of salts. A solution of 
thiamine (0.6 mL of 0.6 mM) and a solution of 1 mL of trace elements to give 3.6 mM 
H3BO3, 1 mM CuSO4, 0.7 mM KI, 0.8 mM FeNa- ethylenediaminetetraacetic acid, 1 mM 
MnSO4, 0.5 mM NaMoO4, and 0.4 mM ZnSO4 was added to 116.7 mL solution of sucrose 
(20 mM, 6.846 g) and urea (15 mM, 0.900 g) in Milli-Q water. This solution was filtered 
sterilely. Basal salts at pH 5.5 and MgSO4 were mixed together and added to the sterile 
solution of thiamine, trace elements, sucrose, and urea. The volume was made to 1 L by 
adding autoclaved Milli-Q water. The final concentration of the phosphate buffer and 
MOPS were 30 mM. 
 
6.4.6. Feeding deuterated Asp to fungal culture and sampling from cultures 
Fungal culture in minimal media was prepared as reported in our groups’ previous work.13 
The fungal mycelium was removed with a sterile blade from the PDA plate and 
homogenized in sterile water using a sterile stick. The fungal inoculum (250 uL/plate) was 
added into the 15 mL minimal media in 18 polystyrene petri plates (60  15 mm). The 
cultures were incubated in rotary shaker at 22 ºC at 70 rpm. Sterile solutions of (2S,3S)-3-
[2H]-Asp, (2S,3S)-2,3-[2H2]-Asp, and (2S)-2,2,3-[
2H3]-Asp were prepared in Milli-Q 
water and fed to loline-producing cultures separately in triplicate on the 6th day of growth. 
The cultures (1.7 mL) were harvested on the 16th day and lyophilized. The lyophilized 
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samples were basified using NaOH (1 M, 100 μL) and diluted using CHCl3 (1 mL). The 
mixture was vortexed, shaked at room temperature at 130 rpm for 1 h, and centrifuged at 
13000 rpm for 15 min. The chloroform layer was separated and filtered into a GC-MS vial. 
The samples were analyzed through GC-MS to measure deuterium incorporation. 
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Chapter 7. Conclusions and future directions 
 
My investigation of ether bridge formation in loline alkaloid biosynthesis started 
when Dr. Juan Pan isolated AcAP, a novel metabolite, from fungi that had a mutated lolO 
gene due to RNAi. I synthesized an authentic sample of (±)-AcAP, demonstrated its 
structure and stereochemistry, and showed its spectroscopic identity with AcAP isolated 
from a lolO mutant.  
In order to determine whether AcAP was an intermediate or a shunt product, I 
synthesized 2´,2´,2´,3-[2H4]-AcAP. Through feeding of 2´,2´,2´,3-[
2H4]-AcAP to fungal 
cultures, Dr. Juan Pan established that AcAP is an intermediate in the loline alkaloid 
biosynthesis, not a shunt product. This finding let us establish AcAP as the LolO substrate 
and NANL as the first loline produced in loline alkaloid biosynthesis.  
However, this experiment did not explain what was the product of LolO-catalyzed 
oxidation of AcAP, and whether LolO alone, or in combination with other enzymes, 
installed the ether bridge in AcAP. Through the feeding of (±)-AcAP to yeast modified 
with the lolO gene, Dr. Juan Pan established that NANL is the product of LolO oxidation 
of AcAP. This result implied that LolO catalyzed two C–H activations of AcAP and both 
C–O bond-forming reactions during the formation of the ether bridge in NANL, a very 
unusual transformation. In addition, initial work by Dr. Wei-chen Chang further confirmed 
this finding through the feeding of AcAP to purified LolO enzyme. He also observed a 
hydroxylated product of AcAP, a previously unknown metabolite. 
In order to resolve whether initial hydroxylation of AcAP catalyzed by LolO 
occurred at C(2) or C(7), I synthesized (±)-7,7-[2H2]- and (±)-2,2,8-[
2H3]-AcAP. Dr. Juan 
Pan subjected (±)-AcAP, (±)-7,7-[2H2]-, and (±)-2,2,8-[
2H3]-AcAP to the LolO oxidation 
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reaction under single-oxidation conditions. She observed a very large KIE in the case of 
(±)-2,2,8-[2H3]-AcAP only, demonstrating that LolO abstracted the C(2) H atom first to 
produce 2-hydroxy-AcAP. Further support for the structure of 2-hydroxy-AcAP was 
obtained upon its isolation by Dr. Juan Pan. I used the isolated material to establish the 
structure and stereochemistry of 2-endo-2-hydroxy-AcAP by NMR. 
Next, I wanted to investigate the stereochemical course of C–H bond abstraction 
(exo or endo) by LolO from C(2) and C(7) of AcAP. In order to do this, I synthesized trans- 
and cis-3-[2H]-Pro and (2S,3R)-3-[2H]- and (2S,3S)-2,3-[2H2]-Asp. Feedings to loline-
producing cultures conducted by both Dr. Juan Pan (Pro) and me (Asp) showed that the 
endo H atom was abstracted from both the C(2) and C(7) positions of AcAP en route to 
ether bridge formation in loline alkaloid biosynthesis (Scheme 1.4). 
In summary, I was able to investigate the ether bridge formation with the help of 
our collaborators. There are still many unanswered questions remaining regarding the 
biosynthesis of the loline alkaloids. Dr. Wei-chen Chang observed that LolO seems to be 
consuming its unnatural enantiomer (Figure 4.2), so in a future study, one could study the 
ability of LolO to oxidize a range of substrates. To better understand the structure of LolO, 
X-ray crystallization of LolO with AcAP would be helpful. 
To understand the kinetics and mechanism of the second C–H activation event 
catalyzed by LolO, one could isolate more 7,7-[2H2]-2-hydroxy-AcAP and subject it to 
LolO oxidation again. Alternatively, one could synthesize 7,7-[2H2]-2-endo-2-hydroxy-
AcAP to accomplish the same goal. One could also study the crystal structure of (±)-AcAP 
and try to understand why the crystal I was able to grow had such an unusual structure 
(Figure 2.18). 
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With all my heart, I wish very well for all future researchers and graduate students 
who would be working to answer all the above questions and any other questions which 
may arise. 
  
 104 
Appendix
 
 
 
 
Figure A.1. HRMS of ()-AcAP 
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Figure A.2. 1H–13C HMBC of ()-AcAP 
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Figure A.3. HRMS of (±)1-epi-AcAP 
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Figure A.4. 1HNMR of equimolar mixture of synthetic and isolated AcAP. 
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Figure A.5. 13C NMR of equimolar mixture of synthetic and isolated AcAP. 
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Figure A.6. GC-MS of equimolar mixture of synthetic and isolated AcAP. 
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Table A.1: Crystal data and structure refinement for ()-AcAP 
 
  
Empirical formula   C18 H33 Cl N4 O2  
 
Formula weight 
 
372.93  
Temperature  
 
90.0(2) K  
Wavelength (Å) 
 
1.54178 A  
Crystal system, space group 
 
Monoclinic, 
space group 
 
C2/c  
Unit cell dimensions  
 
 
A (Å) 
 
20.2461(7) 
 (°) 
 
90 
B (Å) 
 
9.7027(4) 
 (°) 
 
100.562(2) 
c (Å) 
 
10.1617(4) 
 (°) 
 
90 
Volume (Å3) 
 
1962.36(13)  
Z 
 
4 
Calculated density (Mg/m3 ) 
 
1.262 
Absorption coefficient (mm-1) 
 
1.871 
F (000) 
 
808 
Crystal size (mm) 
 
0.230 x 0.060 x 0.020 
 range for data collection (°) 
 
4.443 to 68.364 
Limiting indices -23<=h<=24, 
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 -11<=k<=11 
 
 -12<=l<=5 
 
Reflections collected / unique 
 
12509 / 1788 
 
 
[R(int) = 0.0481] 
Completeness to  = 67.679 
 
99.4 % 
Absorption correction Semi-empirical from equivalents  
 
Max. transmission 
 
0.971  
Min. transmission 
 
0.754  
Refinement method  Full-matrix least-squares on F2  
 
Data/restraints/parameters 
 
1788 / 36 / 129 
Goodness-of-fit on F2  
 
1.068 
Final R indices [I>2sigma(I)] 
 
R1 = 0.0486, 
 
 
R2 = 0.1416  
R indices (all data) 
 
 R1 = 0.0500, 
 
 
R2 = 0.1429 
Extinction coefficient 
 
0.0010(3)  
Largest diff. peak and hole e.A-3  0.823 and -0.207 
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Table A.2: Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(Å2 x 103) for ()-AcAP. U(eq) is defined as one third of the trace of the orthogonalized 
Uij tensor.  
 x y z U(eq) 
 
     
N (1) 5656(1)    7822(2)  2630(2)  30 (1) 
 
N (2) 6412(1) 4380(2)   2918(2) 29 (1) 
 
O (1) 7544(1) 4168(2) 3213(2)  38 (1) 
 
C (2) 6379(1) 5838(2)  2612(2)   29 (1) 
 
C (3) 6025(1) 6176(2) 1188(2)  35 (1) 
 
C (4) 5866(1)    7688(2)  1289(2) 35 (1) 
 
C (5) 5893(1)  9118(2) 3362(2) 39 (1) 
 
C (6) 6528(1) 8708(3) 4313(2) 35 (1) 
 
C (7) 6349(2)   7273(3) 4772(3)  32 (1) 
 
C (1) 5966(1) 6628(2)  3485(2)  29 (1) 
 
C (5´) 5893(1)  9118(2)  3362(2)   39 (1) 
 
C (6´) 6152(12) 8737(18) 4740(16) 35 (1) 
 
C (7´) 6506(11) 7370(20)  4530(30)  32 (1) 
 
C (1´) 5966(1)  6628(2)  3485(2)    29 (1) 
 
C (8) 6984(1)  3651(2)  3160(2)       28 (1) 
 
C (9) 6890(1)  2136(2) 3372(2)     34 (1) 
 
C (1) 5000  2720(1)   2500  31 (1) 
 
  
  
 113 
Table A.3: Bond lengths [Å] and angles [°] for ()-AcAP. 
 
  
N(1)-C(5')  1.494(3)  
 
N(1)-C(5)  1.494(3)  
 
N(1)-C(4)  1.505(3)  
 
N(1)-C(1')     1.512(3)  
 
N(1)-C(1)  1.512(3)  
 
N(1)-H(1N)  1.3114(19)  
 
N(2)-C(8) 1.341(3)  
 
N(2)-C(2)  1.447(3)  
 
N(2)-H(2N)  0.95(3)  
 
O(1)-C(8)  1.233(3)  
 
C(2)-C(3)    1.528(3)  
 
C(2)-C(1') 1.532(3)  
 
C(2)-C(1)  1.532(3)  
 
C(2)-H(2)   1.0000  
 
C(3)-C(4)  1.510(3)  
 
C(3)-H(3A)   0.9900  
 
C(3)-H(3B)  0.9900  
 
C(4)-H(4A)   0.9900  
 
C(4)-H(4B)   0.9900  
 
C(5)-C(6)   1.513(3)  
 
C(5)-H(5A)  0.9900  
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C(5)-H(5B) 0.9900 
 
C(6)-C(7)  1.532(3)  
 
C(6)-H(6A)  0.9900  
 
C(6)-H(6B)    0.9900  
 
C(7)-C(1)  1.528(3)  
 
C(7)-H(7A)  0.9900  
 
C(7)-H(7B)   0.9900  
 
C(1)-H(1)  1.0000  
 
C(5')-C(6')  1.450(15) 
  
C(5')-H(5'1)       0.9900  
 
C(5')-H(5'2) 0.9900  
 
C(6')-C(7')  1.543(18)  
 
C(6')-H(6'1)   0.9900  
 
C(6')-H(6'2)  0.9900  
 
C(7')-C(1')    1.554(17)  
 
C(7')-H(7'1)   0.9900  
 
C(7')-H(7'2)    0.9900  
 
C(1')-H(1')  1.0000  
 
C(8)-C(9)  1.503(3)  
 
C(9)-H(9A) 0.9800  
 
C(9)-H(9B) 0.9800  
 
C(9)-H(9C)  0.9800  
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C(5')-N(1)-C(4) 113.95(18) 
 
C(5)-N(1)-C(4)  113.95(18)  
 
C(5')-N(1)-C(1') 107.33(16) 
 
C(4)-N(1)-C(1') 107.33(16) 
 
C(5)-N(1)-C(1)   107.33(16) 
 
C(4)-N(1)-C(1)   107.33(16) 
 
C(5')-N(1)-H(1N) 105.8(17)  
 
C(5)-N(1)-H(1N)   105.8(17)  
 
C(4)-N(1)-H(1N) 110.9(2)  
 
C(1')-N(1)-H(1N) 111.5(16)  
 
C(1)-N(1)-H(1N) 111.5(16)  
 
C(8)-N(2)-C(2) 123.97(18) 
 
C(8)-N(2)-H(2N) 117.8(18)  
 
C(2)-N(2)-H(2N)  118.1(18)  
 
N(2)-C(2)-C(3) 114.07(18)  
 
N(2)-C(2)-C(1')  111.90(16)  
 
C(3)-C(2)-C(1') 103.25(17)  
 
N(2)-C(2)-C(1) 111.90(16)  
 
C(3)-C(2)-C(1) 103.25(17)  
 
N(2)-C(2)-H(2)  109.1  
 
C(3)-C(2)-H(2) 109.1  
 
C(1)-C(2)-H(2) 109.1  
 
C(4)-C(3)-C(2) 102.31(17)  
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C(4)-C(3)-H(3A)   111.3  
 
C(2)-C(3)-H(3A) 111.3  
 
C(4)-C(3)-H(3B)  111.3  
 
 C(2)-C(3)-H(3B)   111.3  
 
H(3A)-C(3)-H(3B)  109.2  
 
N(1)-C(4)-C(3) 104.14(17)  
 
N(1)-C(4)-H(4A)  110.9 
 
C(3)-C(4)-H(4A) 110.9 
 
N(1)-C(4)-H(4B)  110.9 
 
C(3)-C(4)-H(4B)  110.9 
 
H(4A)-C(4)-H(4B)  108.9  
 
N(1)-C(5)-C(6)  104.66(18) 
 
N(1)-C(5)-H(5A) 110.8 
 
C(6)-C(5)-H(5A) 110.8 
 
N(1)-C(5)-H(5B)  110.8 
 
C(6)-C(5)-H(5B) 110.8 
 
H(5A)-C(5)-H(5B) 108.9 
 
C(5)-C(6)-C(7)  102.3(2)  
 
C(5)-C(6)-H(6A) 111.3  
 
C(7)-C(6)-H(6A) 111.3  
 
C(5)-C(6)-H(6B)   111.3  
 
C(7)-C(6)-H(6B) 111.3  
 
H(6A)-C(6)-H(6B) 109.2  
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C(1)-C(7)-C(6)  102.86(19)  
 
C(1)-C(7)-H(7A)  111.2  
 
C(6)-C(7)-H(7A)  111.2  
 
C(1)-C(7)-H(7B) 111.2  
 
C(6)-C(7)-H(7B)  111.2  
 
H(7A)-C(7)-H(7B)  109.1 
 
N(1)-C(1)-C(7)    105.65(17)  
 
N(1)-C(1)-C(2)  105.27(16)  
 
C(7)-C(1)-C(2)  117.05(19)  
 
N(1)-C(1)-H(1)  109.5  
 
C(7)-C(1)-H(1)  109.5  
 
C(2)-C(1)-H(1)  109.5 
 
C(6')-C(5')-N(1)  107.0(7)  
 
C(6')-C(5')-H(5'1)  110.3 
 
N(1)-C(5')-H(5'1)  110.3 
 
C(6')-C(5')-H(5'2) 110.3 
 
N(1)-C(5')-H(5'2)     110.3 
 
H(5'1)-C(5')-H(5'2)  108.6  
 
C(5')-C(6')-C(7') 100.4(14)  
 
C(5')-C(6')-H(6'1) 111.7  
 
C(7')-C(6')-H(6'1) 111.7  
 
C(5')-C(6')-H(6'2) 111.7  
 
C(7')-C(6')-H(6'2) 111.7  
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H(6'1)-C(6')-H(6'2)    109.5  
 
C(6')-C(7')-C(1')   101.8(13)  
 
C(6')-C(7')-H(7'1) 111.4  
 
C(1')-C(7')-H(7'1)  111.4  
 
C(6')-C(7')-H(7'2)  111.4  
 
C(1')-C(7')-H(7'2)   111.4  
 
H(7'1)-C(7')-H(7'2)  109.3  
 
N(1)-C(1')-C(2) 105.27(16) 
 
N(1)-C(1')-C(7') 101.8(9)  
 
C(2)-C(1')-C(7')      103.6(10)  
 
N(1)-C(1')-H(1') 114.9  
 
C(2)-C(1')-H(1')  114.9  
 
C(7')-C(1')-H(1') 114.9  
 
O(1)-C(8)-N(2)  123.4(2)  
 
O(1)-C(8)-C(9) 122.1(2) 
 
N(2)-C(8)-C(9)  114.51(19)  
 
C(8)-C(9)-H(9A)  109.5  
 
C(8)-C(9)-H(9B) 109.5   
 
H(9A)-C(9)-H(9B) 109.5  
 
C(8)-C(9)-H(9C)     109.5  
 
H(9A)-C(9)-H(9C)     109.5  
 
H(9B)-C(9)-H(9C) 109.5  
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Table A.4: Anisotropic displacement parameters (Å2 x 103) for ()-AcAP. The anisotropic 
displacement factor exponent takes the form: -2 π2 [h2 a*2 U11 + ... + 2 h k a* b* U12] 
 
  
U11 
 
 
U22 
 
U33 
 
U23 
 
U13 
 
U12 
 
       
N (1) 34 (1) 25 (1) 30 (1)   1 (1)   2 (1) –2 (1) 
 
N (2) 29 (1) 27 (1) 32 (1)   0 (1)   7 (1) –2 (1) 
 
O (1) 31 (1) 38 (1) 44 (1)   5 (1)   4 (1) –1 (1) 
 
C (2) 30 (1) 28 (1) 30 (1)   2 (1)   6 (1) –2 (1) 
 
C (3) 40 (1) 38 (1) 27 (1)   2 (1)   9 (1) –2 (1) 
 
C (4) 38 (1) 37 (1) 30 (1)   6 (1)   5 (1) –2 (1) 
 
C (5) 43 (1) 27 (1) 42 (1) –2 (1) – 3 (1) –4 (1) 
 
C (6) 38 (2) 34 (1) 31 (1) –3 (1)   0 (1) –7 (1) 
 
C (7) 35 (2) 34 (1) 26 (1) –1 (1)   4 (1)   0 (1) 
 
C (1) 30 (1) 29 (1) 26 (1)   1 (1)   2 (1)   0 (1) 
 
C (5´) 43 (1) 27 (1) 42 (1) – 2 (1) –3 (1) –4 (1) 
 
C (6´) 38 (2) 34 (1) 31 (1) –3 (1)   0 (1) –7 (1) 
 
C (7´) 35 (2) 34 (1) 26 (1) –1 (1)   4 (1)   0 (1) 
 
C (1´) 30 (1) 29 (1) 26 (1)   1 (1)   2 (1)   0 (1) 
 
C (8) 31 (1) 32 (1) 21 (1) –2 (1)   5 (1) –1 (1) 
 
C (9) 39 (1) 29 (1) 31 (1) –1 (1)   3 (1)   1 (1) 
 
C (1) 18 (1) 29 (1) 44 (1)   0    1 (1)   0 
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Table A.5: Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 
103) for ()-AcAP.         
 
  
x 
 
 
y 
 
z 
 
U (eq) 
 
     
H (1N) 5000 7830(50) 2500  64(13)  
 
H (2N) 6000 (15) 3900(30)  2880(30) 51(8)  
 
H (2) 6845 6223   2759 35  
 
H (3A) 6324  6015 534 42  
 
H (3B) 5611  5623 929 42  
 
H (4A) 6266  8262 1249 42  
 
H (4B) 5497    7968 558 42  
 
H (5A) 5551 9470  3861 47  
 
H (5B) 5988  9839  2733    47  
 
H (6A) 6629  9355  5077 42 
 
H (6B) 6917  8669 3850     42 
 
H (7A) 6758  6737 5133 38  
 
H (7B) 6063 7336 5464 38  
 
H (1) 5601 6019  3700 34 
 
H (5´1) 6249  9558   2959  47 
 
H (5´2) 5516 9777 3319 47 
 
H (6´1) 5786 8600  5253 42  
 
H (6´2) 6472 9431 5197  42  
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H (7´1) 6613    6834 5372   38 
H (7´2) 6923  7528 4175 38 
 
H (1´) 5639  6053 3874 34 
 
H (9A) 7025   1617  2636 50  
 
H (9B) 6417  1950 3396  50  
 
H (9C) 7169 1853   4222   50  
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Table A 6: Torsion angles [°] for ()-AcAP.  
  
C(8)-N(2)-C(2)-C(3)   113.2(2)  
 
C(8)-N(2)-C(2)-C(1')    -130.07(19)  
 
C(8)-N(2)-C(2)-C(1) -130.07(19)  
 
N(2)-C(2)-C(3)-C(4)   162.39(18)  
 
C(1')-C(2)-C(3)-C(4)  40.7(2)  
 
C(1)-C(2)-C(3)-C(4)     40.7(2)  
 
C(5')-N(1)-C(4)-C(3)  142.14(19)  
 
C(5)-N(1)-C(4)-C(3)    142.14(19)  
 
C(1')-N(1)-C(4)-C(3)   23.4(2)  
 
C(1)-N(1)-C(4)-C(3)   23.4(2)  
 
C(2)-C(3)-C(4)-N(1) -39.6(2)  
 
C(4)-N(1)-C(5)-C(6) -96.9(2) 
 
C(1)-N(1)-C(5)-C(6)  21.9(2)  
 
N(1)-C(5)-C(6)-C(7)  -38.6(2) 
 
C(5)-C(6)-C(7)-C(1)  40.4(3) 
 
C(5)-N(1)-C(1)-C(7)  3.7(2)  
 
C(4)-N(1)-C(1)-C(7)  126.6(2) 
 
C(5)-N(1)-C(1)-C(2) -120.81(19)  
 
C(4)-N(1)-C(1)-C(2)   2.1(2)  
 
 C(6)-C(7)-C(1)-N(1)    -27.3(3)  
 
C(6)-C(7)-C(1)-C(2)      89.5(2)  
 
N(2)-C(2)-C(1)-N(1)    -149.51(17)  
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C(3)-C(2)-C(1)-N(1) -26.4(2)  
 
N(2)-C(2)-C(1)-C(7)  93.5(2)  
 
C(3)-C(2)-C(1)-C(7)    -143.4(2) 
 
C(4)-N(1)-C(5')-C(6')  -135.3(10)  
 
C(1')-N(1)-C(5')-C(6')   -16.6(10)  
 
N(1)-C(5')-C(6')-C(7')   38.9(17)  
 
C(5')-C(6')-C(7')-C(1')  -46(2)  
 
C(5')-N(1)-C(1')-C(2) -120.81(19)  
 
C(4)-N(1)-C(1')-C(2)   2.1(2) 
 
C(5')-N(1)-C(1')-C(7')  -13.0(11) 
 
C(4)-N(1)-C(1')-C(7')  109.9(11)  
 
N(2)-C(2)-C(1')-N(1)  -149.51(17)  
 
C(3)-C(2)-C(1')-N(1) -26.4(2)  
 
N(2)-C(2)-C(1')-C(7')  104.0(10)  
 
C(3)-C(2)-C(1')-C(7')  -132.9(10)  
 
C(6')-C(7')-C(1')-N(1)  35.9(18)  
 
C(6')-C(7')-C(1')-C(2)  145.1(15)  
 
C(2)-N(2)-C(8)-O(1)   3.9(3)  
 
C(2)-N(2)-C(8)-C(9) -176.46(18) 
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Symmetry transformations used to generate equivalent atoms:  
 
Table A.7: Hydrogen bonds for ()-AcAP [Å and °]. 
     
D-H...A d(D-H) d(H...A) d(D...A) <(DHA)  
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